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Microbial Components  Species  TLR Usage  References 
Triacyl lipopeptides  Bacteria and mycobacteria  TLR1  (Takeuchi et al., 2002) 
Peptidoglycan  Gram‐positive bacteria  TLR2  (Takeuchi et al., 
1999;Schwandner et al., 
1999) 
Fimbrillin  Porphyromonas gingivalis  TLR2/TLR4  (Davey et al., 2008) 
Polysaccharide A  Bacteroides fragilis  TLR2  (Round et al., 2011) 
Lipoarabinomannan  Mycobacteria  TLR2  (Means et al., 1999) 
Porins  Neisseria  TLR2  (Massari et al., 2002) 
Lipoteichoic acid  Gram‐positive bacteria  TLR2/TLR6  (Schwandner et al., 1999) 
Lipopolysaccharide   Gram‐negative bacteria  TLR4  (Poltorak et al., 1998) 
Flagellin  Flagellated bacteria  TLR5  (Hayashi et al., 2001) 
Diacyl lipopeptides  Mycoplasma  TLR6  (Takeuchi et al., 2001) 
CpG‐containing DNA  Bacteria and mycobacteria  TLR9  (Hemmi et al., 2000) 
Not determined  Not determined  TLR10  ‐ 


































































































































































































































































4.5. Protective effects of prebiotics or prebiotic candidates on 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Target taxon  Primer  Sequence (5’‐3’) Fragment size (bp)  Reference
Bifidobacterium spp.  F‐bifido  cgc gtc ygg tgt gaa ag 244 [10]
R‐bifido  ccc cac atc cag cat cca
Lactobacillus spp.  Lacto‐F  agc agt agg gaa tct tcc a 341 [21,55]
Lacto‐R  cac cgc tac aca tgg ag
Clostridium leptum subgroup sg‐Clept‐F  gca caa gca gtg gag t 239 [32,48]
sg‐Clept‐R  ctt cct ccg ttt tgt caa
Clostridium coccoides group g‐Ccoc‐F  aaa tga cgg tac ctg act aa 440 [32]
g‐Ccoc‐R  ctt tga gtt tca ttc ttg cga a
Roseburia spp.  RosF  tac tgc att gga aac tgt cg  230 [27]
RosR  cgg cac cga aga gca at
Firmicutes phylum  Firm934F  gga gya tgt ggt tta att cga agc a 126 [18]
Firm1060R  agc tga cga caa cca tgc ac
Bacteroidetes phylum  Bact934F  gga rca tgt ggt tta att cga tga t 126 [18]
Bact1060R  agc tga cga caa cca tgc ag
Bacteroides spp.  BacAll_2F  gtc agt tgt gaa agt ttg c 127 [1]
BacAll_2R  caa tcg gag ttc ttc gtg 
Prevotella spp.  PrevF  cac  caa ggc gac gat ca 283 [27]
PrevR  gga taa cgc cyg gac ct
Alistipes spp.  Alis F1‐124  tta gag atg ggc atg cgt tgt 320 This study
Alis R1‐423  tga atc ctc cgt att acc gcg
Bac. fragilis group  Bfr ‐F  ctg aac cag cca agt agc g 230 [29]
Bfr ‐R  ccg caa act ttc aca act gac tta
Desulfovibrio spp.  DSV691‐F  ccg tag ata tct gga gga aca tca g 136 [14]
DSV826‐R  aca tct agc atc cat cgt tta cag c
V2‐V3 16S rRNA  region*  HDA1  act cct acg gga ggc agc agt 200 [55]
HDA2  gta tta ccg cgg ctg ctg gca c









Target taxon  Primer  Sequence (5’‐3’) Fragment size (bp)  Reference
Faecalibacterium prausnitzii *
 
Fprau 07  cca tga att gcc ttc aaa act gtt 140 [51]
Fprau 02  gag cct cag cgt cag ttg gt
Akkermansia muciniphila*  AM1  cag cac gtg aag gtg ggg ac 327 [9]
AM2  cct tgc ggt tgg ctt cag at
Bifidobacterium bifidum*  BiBIF‐1  cca cat gat cgc atg tga ttg 278 [33]
BiBIF‐2    ccg aag gct tgc tcc caa a
Bifidobacterium breve*  BiBRE‐1  ccg gat gct cca tca cac 288 [33]
BiBRE‐2  aca aag tgc ctt gct ccc t
Bifidobacterium adolescentis* BiADO‐1  ctc cag ttg gat gca tgt c 279 [33]
BiADO‐2  cga agg ctt gct ccc agt





BiCATg‐1    cgg atg ctc cga ctc ct 289 [33]
BiCATg‐2    cga agg ctt gct ccc gat




Bacteroides vulgatus*  B.vulga‐F  aag gga gcg tag atg gat gtt ta 192 [22]
B.vulga‐R  cga gcc tca atg tca gtt gc
Bacteroides uniformis*  B.uni F2  ata acg agc gca acc ctt atc  190 This study
B.uni R2  tta ggg att agc atc acg tcg
Bacteroides thetaiotaomicron*  B_theta F  cgt tcc att agg cag ttg gt 110 [47]
B_theta R  aca cgg tcc aaa ctc cta cg











































































































































1  169  Healthy   2/6  Bacteroidetes Bacteroides 94 
Remission  1/6 
Relapse  5/6 
2  169  Healthy   4/6  Bacteroidetes  Alistipes  97 
Remission  2/6 
Relapse  2/6 














  1.   Ahmed S, Macfarlane GT, Fite A, Mcbain AJ, Gilbert P, Macfarlane S. (2007) Mucosa‐associated bacterial 
diversity in relation to human terminal ileum and colonic biopsy samples. Applied and Environmental 
Microbiology. 73:7435‐7442. 
  2.   Ardizzone S. (2003) Ulcerative Colitis. Orphanet encyclopedia. http://www.orpha.net/data/patho/GB/uk‐
UC.pdf. 
  3.   Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR et al.. (2011) Enterotypes of the human 
gut microbiome. Nature. 473:174‐180. 
  4.   Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y et al.. (2011) Induction of Colonic 
Regulatory T Cells by Indigenous Clostridium Species. Science. 331:337‐341. 
  5.   Bernbom N, Norrung B, Saadbye P, Molbak L, Vogensen FK, Licht TR. (2006) Comparison of methods and 
animal models commonly used for investigation of fecal microbiota: Effects of time, host and gender. Journal of 
Microbiological Methods. 66:87‐95. 
  6.   Binder V. (1970) A Comparison Between Clinical State, Macroscopic and Microscopic Appearances of Rectal 
Mucosa, and Cytologic Picture of Mucosal Exudate in Ulcerative Colitis. Scandinavian Journal of 
Gastroenterology. 5:627‐632. 
  7.   Campieri M, Gionchetti P. (2001) Bacteria as the cause of ulcerative colitis. Gut. 48:132‐135. 
  8.   Codling C, O'Mahony L, Shanahan F, Quigley EMM, Marchesi JR. (2010) A Molecular Analysis of Fecal and 
Mucosal Bacterial Communities in Irritable Bowel Syndrome. Digestive Diseases and Sciences. 55:392‐397. 
  9.   Collado MC, Derrien M, Isolauri E. (2007) Intestinal integrity and Akkermansia muciniphila, a mucin‐degrading 
member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environmental 
Microbiology. 73:7767‐7770. 
  10.   Delroisse JM, Boulvin AL, Parmentier I, Dauphin RD, Vandenbol M, Portetelle D. (2008) Quantification of 
Bifidobacterium spp. and Lactobacillus spp. in rat fecal samples by real‐time PCR. Microbiological Research. 
163:663‐670. 
  11.   Denman SE, McSweeney CS. (2006) Development of a real‐time PCR assay for monitoring anaerobic fungal and 
cellulolytic bacterial populations within the rumen. Fems Microbiology Ecology. 58:572‐582. 
  12.   Derrien M, Vaughan EE, Plugge CM, de Vos WM. (2004) Akkermansia muciniphila gen. nov., sp nov., a human 
intestinal mucin‐degrading bacterium. International Journal of Systematic and Evolutionary Microbiology. 
54:1469‐1476. 
  13.   Farrell RJ, Peppercorn MA. (2002) Ulcerative colitis. Lancet. 359:331‐340. 
  14.   Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E et al.. (2004) Identification and 
quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut. 53:523‐529. 





  16.   Grimoud J, Durand H, de Souza S, Monsan P, Ouarne F, Theodorou V et al.. (2010) In vitro screening of 
probiotics and synbiotics according to anti‐inflammatory and anti‐proliferative effects. International Journal of 
Food Microbiology. 144:42‐50. 
  17.   Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. (2010) From the gut to the 
peripheral tissues: the multiple effects of butyrate. Nutrition Research Reviews. 23:366‐384. 
  18.   Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K. (2008) Development of a real‐time PCR method for Firmicutes 
and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters 
in Applied Microbiology. 47:367‐373. 
  19.   Haarman M, Knol J. (2005) Quantitative real‐time PCR assays to identify and quantify fecal Bifidobacterium 
species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology. 71:2318‐2324. 
  20.   Hart AL, Al‐Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC et al.. (2005) Characteristics of intestinal 
dendritic cells in inflammatory bowel diseases. Gastroenterology. 129:50‐65. 
  21.   Heilig HGHJ, Zoetendal EG, Vaughan EE, Marteau P, Akkermans ADL, de Vos WM. (2002) Molecular diversity 
of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific 
amplification of 16S ribosomal DNA. Applied and Environmental Microbiology. 68:114‐123. 
  22.   Huijsdens XW, Linskens RK, Mak MT, Meuwissen SGM, Vandenbroucke‐Grauls CMJE, Savelkoul PHM. (2002) 
Quantification of bacteria adherent to gastrointestinal mucosa by real‐time PCR. Journal of Clinical 
Microbiology. 40:4423‐4427. 
  23.   Isaacs K, Herfarth H. (2008) Role of Probiotic Therapy in IBD. Inflammatory Bowel Diseases. 14:1597‐1605. 
  24.   Kleerebezem M, Vaughan EE. (2009) Probiotic and Gut Lactobacilli and Bifidobacteria: Molecular Approaches 
to Study Diversity and Activity. Annual Review of Microbiology. 63:269‐290. 
  25.   Lamine F, Eutamene H, Fioramonti J, Bueno L, Theodorou V. (2004) Colonic responses to Lactobacillus 
farciminis treatment in trinitrobenzene sulphonic acid‐induced colitis in rats. Scandinavian Journal of 
Gastroenterology. 39:1250‐1258. 
  26.   Langholz E, Munkholm P, Davidsen M, Binder V. (1994) Course of Ulcerative‐Colitis ‐ Analysis of Changes in 
Disease‐Activity Over Years. Gastroenterology. 107:3‐11. 
  27.   Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK et al.. (2010) Gut 
Microbiota in Human Adults with Type 2 Diabetes Differs from Non‐Diabetic Adults. Plos One. 5:1‐10. 
  28.   Leser TD, Lindecrona RH, Jensen TK, Jensen BB, Moller K. (2000) Changes in bacterial community structure in 
the colon of pigs fed different experimental diets and after infection with Brachyspira hyodysenteriae. Applied 
and Environmental Microbiology. 66:3290‐3296. 
  29.   Liu CX, Song YL, McTeague M, Vu AW, Wexler H, Finegold SM. (2003) Rapid identification of the species of the 
Bacteroides fragilis group by multiplex PCR assays using group‐ and species‐specific primers. Fems Microbiology 
Letters. 222:9‐16. 
  30.   Loftus EV. (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and 
environmental influences. Gastroenterology. 126:1504‐1517. 




  32.   Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. (2004) Use of 16S rRNA gene‐targeted group‐specific 
primers for real‐time PCR analysis of predominant bacteria in human feces. Applied and Environmental 
Microbiology. 70:7220‐7228. 
  33.   Matsuki T, Watanabe K, Tanaka R, Oyaizu H. (1998) Rapid identification of human intestinal bifidobacteria by 
16S rRNA‐targeted species‐ and group‐specific primers. Fems Microbiology Letters. 167:113‐121. 
  34.   O'Sullivan DJ, Kullen MJ. (1998) Tracking of probiotic bifidobacteria in the intestine. International Dairy 
Journal. 8:513‐525. 
  35.   Ott SJ, Musfeldt M, Timmis KN, Hampe J, Wenderoth DF, Schreiber S. (2004) In vitro alterations of intestinal 
bacterial microbiota in fecal samples during storage. Diagnostic Microbiology and Infectious Disease. 50:237‐
245. 
  36.   Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J et al.. (2007) A comparative study of the 
preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus 
acidophilus, in the TNBS model of rat colitis. Journal of Applied Microbiology. 103:836‐844. 




  39.   Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI et al.. (2010) Mucolytic Bacteria With 
Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria. American Journal 
of Gastroenterology. 105:2420‐2428. 
  40.   Pullan RD, Thomas GAO, Rhodes M, Newcombe RG, Williams GT, Allen A et al.. (1994) Thickness of Adherent 
Mucus Gel on Colonic Mucosa in Humans and Its Relevance to Colitis. Gut. 35:353‐359. 
  41.   Qin JJ, Li RQ, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al.. (2010) A human gut microbial gene 
catalogue established by metagenomic sequencing. Nature. 464:59‐70. 
  42.   Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. (2006) Anti‐inflammatory effects of 
bifidobacteria by inhibition of LPS‐induced NF‐kappa B activation. World Journal of Gastroenterology. 12:3729‐
3735. 
  43.   Sartor RB. (2008) Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. 
Proceedings of the National Academy of Sciences of the United States of America. 105:16413‐16414. 
  44.   Sartor RB. (2006) Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature Clinical 
Practice Gastroenterology & Hepatology. 3:390‐407. 
  45.   Sartor RB. (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: 
Antibiotics, probiotics, and prebiotics. Gastroenterology. 126:1620‐1633. 
  46.   Segain JP, de la Bletiere DR, Bourreille A, Leray V, Gervois N, Rosales C et al.. (2000) Butyrate inhibits 
inflammatory responses through NF kappa B inhibition: implications for Crohn's disease. Gut. 47:397‐403. 





  48.   Shen J, Zhang BR, Wei GF, Pang X, Wei H, Li M et al.. (2006) Molecular profiling of the Clostridium leptum 
subgroup in human fecal microflora by PCR‐denaturing gradient gel electrophoresis and clone library analysis. 
Applied and Environmental Microbiology. 72:5232‐5238. 
  49.   Shirasawa Y, Shibahara‐Sone H, Iino T, Ishikawa F. (2010) Bifidobacterium bifidum BF‐1 suppresses 
Helicobacter pylori‐induced genes in human epithelial cells. Journal of Dairy Science. 93:4526‐4534. 
  50.   Sokol H, Lay C, Seksik P, Tannock GW. (2008) Analysis of bacterial bowel communities of IBD patients: What 
has it revealed? Inflammatory Bowel Diseases. 14:858‐867. 
  51.   Sokol H, Seksik P, Furet JP, Firmesse O, Nion‐Larmurier L, Beaugerie L et al.. (2009) Low Counts of 
Faecalibacterium prausnitzii in Colitis Microbiota. Inflammatory Bowel Diseases. 15:1183‐1189. 
  52.   Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T et al.. (2008) Imbalance in intestinal 
microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. International 
Journal of Medical Microbiology. 298:463‐472. 
  53.   Van Passel MWJ, Kant R, Zoetendal EG, Plugge CM, Derrien M, Malfatti SA et al.. (2011) The Genome of 
Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal 
Metagenomes. Plos One. 6:1‐8. 
  54.   Vanderpool C, Yan F, Polk DB. (2008) Mechanisms of Probiotic Action: Implications for Therapeutic 
Applications in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 14:1585‐1596. 
  55.   Walter J, Tannock GW, Tilsala‐Timisjarvi A, Rodtong S, Loach DM, Munro K et al.. (2000) Detection and 
identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and 
species‐specific PCR primers. Applied and Environmental Microbiology. 66:297‐303. 
  56.   Wu XK, Ma CF, Han L, Nawaz M, Gao F, Zhang XY et al.. (2010) Molecular Characterisation of the Faecal 
Microbiota in Patients with Type II Diabetes. Current Microbiology. 61:69‐78. 
  57.   Zeuthen LH, Fink LN, Metzdorff SB, Kristensen MB, Licht TR, Nellemann C et al.. (2010) Lactobacillus 
acidophilus induces a slow but more sustained chemokine and cytokine response in naive foetal enterocytes 
compared to commensal Escherichia coli. Bmc Immunology. doi: 10.1186/1471‐2172‐11‐2. 
  58.   Zhou JS, Gopal PK, Gill HS. (2001) Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), 
Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. 
International Journal of Food Microbiology. 63:81‐90. 
  59.   Zocco MA, Dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M et al.. (2006) Efficacy of Lactobacillus 
GG in maintaining remission of ulcerative colitis. Alimentary Pharmacology & Therapeutics. 23:1567‐1574. 





















































































































































































































































































































































































































































Target taxon  Primer  Sequence (5’‐3’) Fragment size (bp)  Reference
Bifidobacterium spp.  F‐bifido  cgc gtc ygg tgt gaa ag 244 [10] 
R‐bifido  ccc cac atc cag cat cca
Lactobacillus spp.  Lacto‐F  agc agt agg gaa tct tcc a 341 [20,65]
Lacto‐R  cac cgc tac aca tgg ag
Clostridium leptum subgroup  sg‐Clept‐F  gca caa gca gtg gag t 239 [40,56]
sg‐Clept‐R  ctt cct ccg ttt tgt caa
Clostridium coccoides group  g‐Ccoc‐F  aaa tga cgg tac ctg act aa 440 [40] 
g‐Ccoc‐R  ctt tga gtt tca ttc ttg cga a
Roseburia spp.  RosF  tac tgc att gga aac tgt cg  230 [32] 
RosR  cgg cac cga aga gca at
Firmicutes phylum  Firm934F  gga gya tgt ggt tta att cga agc a 126 [19] 
Firm1060R  agc tga cga caa cca tgc ac
Bacteroidetes phylum  Bact934F  gga rca tgt ggt tta att cga tga t 126 [19] 
Bact1060R  agc tga cga caa cca tgc ag
Bacteroides spp.  BacAll_2F  gtc agt tgt gaa agt ttg c 127 [1] 
BacAll_2R  caa tcg gag ttc ttc gtg 
Alistipes spp.  Alis F1‐124  tta gag atg ggc atg cgt tgt 320 [64] 
Alis R1‐423  tga atc ctc cgt att acc gcg
Desulfovibrio spp.  DSV691‐F  ccg tag ata tct gga gga aca tca g 136 [14] 
DSV826‐R  aca tct agc atc cat cgt tta cag c
V2‐V3 16S rRNA  region*  HDA1  act cct acg gga ggc agc agt 200 [65] 
HDA2  gta tta ccg cgg ctg ctg gca c
16S rRNA region*  TBA‐F  cgg caa cga gcg caa ccc 130 [11] 
TBA‐R  cca ttg tag cac gtg tgt agc c






Eubacterium rectale  Eu‐rec_1F  aag gga agc aac gct gtg aa 200 [4] 
Eu‐rec_2R  Cgg tta ggt cac tgg ctt c
Akkermansia muciniphila  AM1  cag cac gtg aag gtg ggg ac 327 [8] 
AM2  cct tgc ggt tgg ctt cag at
Bifidobacterium bifidum  BiBIF‐1  cca cat gat cgc atg tga ttg 278 [41] 
BiBIF‐2    ccg aag gct tgc tcc caa a
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The potential prebiotic properties of arabino-oligosaccharides (AOS) derived from sugar beet pulp was
studied using mixed cultures of human fecal bacteria from patients with ulcerative colitis (UC), in remission
or with active disease, and in healthy controls. These results were compared to those for fructo-oligosaccha-
rides (FOS), which are known to have a prebiotic effect. Fermentation studies were carried out using a
small-scale static batch system, and changes in the fecal microbial communities and metabolites were moni-
tored after 24 h by quantitative real-time PCR and short-chain fatty acid analysis. With a few minor exceptions,
AOS affected the communities similarly to what was seen for FOS. Quantitative real-time PCR revealed that
Bifidobacterium spp. and Lactobacillus spp. were selectively increased after fermentation of AOS or FOS by fecal
microbiota derived from UC patients. The stimulation of growth of Lactobacillus spp. and Bifidobacterium spp.
was accompanied by a high production of acetate and hence a decrease of pH. The fermentation of AOS may
help improve the inflammatory conditions in UC patients through stimulation of bacteria eliciting anti-
inflammatory responses and through production of acetate. AOS may therefore represent a new prebiotic
candidate for reduction of the risk of flare-ups in UC patients. However, human trials are needed to confirm
a health-promoting effect.
During the twentieth century a significant increase in the
incidence of inflammatory bowel diseases has occurred in
Western Europe and North America (33). Ulcerative colitis
(UC) is an idiopathic inflammatory bowel disease character-
ized by chronic inflammation of the colonic mucosa. UC is
usually associated with chronic remissions, which are periods
in which patients are completely symptom free, and relapse
periods, characterized by diarrhea with passage of blood or
mucus, occasional abdominal cramping, and pain as well as, in
severe cases, systemic symptoms, including fever and weight
loss (3, 4). The etiology of inflammatory bowel disease remains
unclear, and no causal infectious agent has been identified.
The commensal bacterial intestinal community represents the
environmental factor most frequently implicated in the devel-
opment of UC (4, 60). Evidence for this implication is provided
by the complete lack of enterocolitis in genetically engineered
germfree mice, rats, and guinea pigs, which reproducibly de-
velop intestinal inflammation within 1 to 4 weeks if they are
colonized with conventional gut bacteria (61). Thus, a dysbiosis
in the composition of the gut microbiota may influence key
mechanisms involved in the inflammatory process of the intes-
tinal mucosa (4, 21, 60). Earlier studies have shown differences
between the intestinal microbiotas of UC patients and those of
healthy subjects (45, 64). In particular, the patients with UC in
relapse are reported to have a small amount of bifidobacteria
(64) and we have observed that the prevalence of lactobacilli in
UC patients is also low compared to that in healthy subjects
(L. K. Vigsnæs et al., submitted for publication). Bifidobacte-
ria and lactobacilli are believed to play an important role in
maintaining intestinal health due to their effect on maturation
and balancing of the immune system (43, 59, 71) and to their
inhibition of pathogens (8, 17, 53). Hence, an underrepresen-
tation of bifidobacteria and lactobacilli may compromise the
colon health and contribute to a higher risk of flare-up in
patients with UC. Maintenance of a healthy gut microbiota and
homeostasis can be promoted by the consumption of indigest-
ible carbohydrates or dietary fibers (11, 27, 37). However, a
sufficient fiber intake is required for the desired effect (14).
Prebiotics are defined as “selectively fermented ingredients
that cause specific changes in composition and/or activity in the
gastointestinal microbiota, which confer benefits upon host
well-being and health” (47). The selective stimulation of spe-
cific colonic bacteria is explained by the capability of these
bacteria to break down the glycosidic linkages in the prebiotic
carbohydrates. These bacteria are able to grow on particular
carbon sources, which are less easily fermented by other mem-
bers of the intestinal community. This provides them with a
selective advantage when competing with other bacterial spe-
cies in a mixed bacterial community such as the human colon
(58). Thus, the monosaccharide composition, glycosidic link-
age, and length of the prebiotics contribute to the relative
increase of beneficial bacteria, including bifidobacteria and
lactobacilli (29, 46, 57). Metabolites produced by bacterial
* Corresponding author. Mailing address: National Food Institute,
Technical University of Denmark, Mørkhøj Bygade 19, 2860 Søborg,
Denmark. Phone: 45 35 88 70 24. Fax: 45 35 88 70 28. E-mail: lokv
@food.dtu.dk.
† Supplemental material for this article may be found at http://aem
.asm.org/.














fermentation of prebiotics include the short-chain fatty acids
(SCFA) acetate, propionate, and butyrate. SCFA have local
and systemic biological effects that are proposed to be benefi-
cial to human health (69). Acetate is important for lowering
the pH of the intestine, thereby inhibiting enteropathogenic
bacteria (16, 17). Butyrate is the preferred energy source for
colonocytes, and studies have shown that butyrate can act as
an anticarcinogenic agent through selective induction of apop-
tosis in colon cancer cells (39, 52, 54). With respect to inflam-
matory bowel diseases, butyrate is important because it
stimulates an anti-inflammatory state in the colon by down-
regulation of proinflammatory cytokine production (62). In-
gestion of prebiotic compounds is considered an alternative
approach for treatment of UC, since an alteration of the co-
lonic microenvironment toward homeostasis may help de-
crease the risk of flare-ups.
Sugar beet pulp, originating from industrial production of
sugar, is rich in pectins, which are heterogeneous molecules
containing regions of homogalacturonan and rhamnogalacturo-
nan I. In sugar beet pectin, the side chains of rhamnogalacturo-
nan I are often rich in arabinan composed of -1,5-linked back-
bone with a high degree of -1,2- and/or 1,3-arabinofuranosyl
substitutions along with some -1,4-linked galactan (40).
Significant potential exists for converting such by-product
streams from industrial bioprocesses into new value-added
products. Several types of nondigestible fibers and oligosac-
charides from plant cell walls have shown the capability to
modulate the human gut microbial composition in in vitro
studies. Some arabino-oligosaccharides (AOS) from sugar beet
pectin (1) and AOS derived from lemon peel (26) are reported
to stimulate the growth of bifidobacteria to the same extent as
the “gold standard” prebiotic fructo-oligosaccharides (FOS)
and inulin, respectively (42, 55, 57). High-molecular-weight
rhamnogalacturonan I from potato pulp was superior to FOS
in stimulating bifidogenic growth (66).
The aim of this work was to examine the potential prebiotic
properties of AOS released from rhamnogalacturonan I during
sequential acid extraction of pectin from sugar beet pulp. Fer-
mentation-induced changes in fecal microbial communities ob-
tained from either healthy subjects or patients with UC in
remission or relapse were investigated to establish whether
fermentation of AOS influenced the fecal communities from
UC patients in the same way as known prebiotic FOS.
MATERIALS AND METHODS
Carbohydrates and chemicals. Sugar beet AOS were obtained from Danisco
A/S (Nakskov, Denmark). The AOS were identical with the substrate described
as “starting material” by Holck and coworkers (24) and was found as linear and
branched arabino-oligosaccharides mainly of 2 to 10 degrees of polymerization
(DP). The content of monosaccharides (mainly arabinose, glucose, and fructose)
contributed to 125 mg/g dry matter. The arabinose moiety in the total sample
accounted for 85 mol%. The ferulic acid content was 36 g/g dry matter (24).
Fructo-oligosaccharides (FOS) (2 to 8 DP) (OraftiR95) were obtained from
Beneo-Orafti (Tienen, Belgium). Unless stated otherwise, chemicals were ob-
tained from Sigma–Aldrich (Steinheim, Germany).
Human volunteers and clinical characteristics of the UC patients. Fecal sam-
ples were obtained from 12 patients with UC and six healthy controls (four
women and two men). Within the UC group, six patients (three women and three
men) were in clinical remission and six patients (three women and three men)
had active disease at the time of sampling according to clinical and endoscopic
criteria (5). The patients were previously diagnosed with UC according to stan-
dardized diagnostic criteria at the Department of Medical Gastroenterology,
Herlev Hospital (28). The study was performed in accordance with the Second
Helsinki Declaration, reported to the Danish Data Protection Agency, and
approved by the Regional Ethics Committee. Four of the six patients with
inactive UC received maintenance treatment with oral mesalazine (anti-inflam-
matory bowel-specific aminosalicylate drug) in a dosage of 1.6 to 2.4 g daily, and
one also received azathioprine (purine analogue immunosuppressive drug) 100
mg daily. One patient received oral olsalazine (anti-inflammatory bowel-specific
azodisalicylate drug) (1 g daily), and one received no treatment. All six patients
with active UC were treated with oral mesalazine in a dosage of 2.4 to 3.2 g daily
as well as topical mesalazine 1 g daily either as an enema (n  5) or as a
suppository (n  1). One patient also received azathioprine 100 mg daily. One
patient had active extensive UC, one left-sided colitis, and the rest either active
proctitis or proctosigmoiditis. One patient with well-established proctitis refused
a new sigmoidoscopy. None of the participants had been treated with antibiotics
for at least 2 months before enrollment, and there was no significant difference
(P 0.57) in the mean age of the participants between the three groups (healthy
control, 41  9 years; UC patients in remission, 41  8 years; and UC patients
in relapse, 45  8 years).
Sample collection and processing. The stool samples were collected at the
home of the participant in airtight containers and stored at 4°C (limited storage
time was encouraged [41]) until delivery to the laboratory, where they were
processed immediately. Feces (200 mg, wet weight) were collected in triplicates
in the middle of each stool sample for DNA extraction and used for the mea-
surement of original bacterial communities. At the same time, feces were pre-
pared for in vitro fermentation in an anaerobic cabinet (Macs Work Station; Don
Whitley), containing 10% H2, 10% CO2, and 80% N2. The fecal samples for in
vitro fermentation were homogenized in 50% glycerol (1:1 dilution) and stored at
80°C until further analysis, as described below. The use of frozen samples
compared to fresh samples in fermentation experiments has been validated
previously (49).
Small-scale in vitro fermentation. A small-scale in vitro fermentation method
was used to assess the effect of AOS on the microbial composition in human
fecal samples. FOS was applied as a standard with known bifidogenic effect
(50). AOS and FOS were sterilely filtrated and added to an autoclaved
minimal basal medium to give a final concentration of 5 g/liter in a reaction
volume of 2 ml. The minimal basal medium contained 2 g/liter of peptone
water, 1 g/liter of yeast extract, 0.1 g/liter of NaCl, 0.04 g/liter of K2HPO4,
0.04 g/liter of KH2PO4, 0.01 g/liter of MgSO4  7H2O, 0.01 g/liter of
CaCl2  2H2O, 2 g/liter of NaHCO3, 0.5 g/liter of bile salts, 0.5 g/liter of
L-cysteine hydrochloride, 50 mg/liter of hemin, 10 l/liter of vitamin K1, 2
ml/liter of Tween 80 (VWR, Darmstadt, Germany), and 0.05‰ (wt/vol)
resazurin solution. The pH of the minimal medium with added FOS or AOS
was adjusted to 7, and the solutions were reduced overnight in an anaerobic
cabinet. Fecal samples were defrosted in an anaerobic cabinet, and 10%
(wt/vol) fecal slurry was prepared by mixing of the samples with anoxic PBS
(Oxoid, Greve, Denmark). The reduced minimal medium with added FOS or
AOS was distributed into 3.8-ml sterile screw-cap vials (Nunc) and inoculated
to a final concentration of 1% (wt/vol) feces. Caps were loosely placed on the
vials to allow gas exchange but avoid evaporation. Each fermentation exper-
iment for the fecal sample of each subject was carried out in triplicates for
each carbohydrate source. A parallel incubation with no added substrate was
used as a control for the SCFA analysis and pH measurements. The fermen-
tation was non-pH controlled and nonstirred, due to the low reaction volume,
and was carried out in an anaerobic cabinet at 37°C. After 24 h of fermen-
tation, the pH of the 2-ml fermentation samples was measured (pH indicator
strips, pH 2.0 to 9.0; Merck) in the anaerobic cabinet, and subsequently a
1-ml fermentation sample was taken out for extraction of bacterial DNA and
SCFA analysis, respectively.
Extraction of bacterial DNA. DNA was extracted from each of the triplicate
fecal samples and each of the triplicate fermentation samples using the QIAamp
DNA stool minikit (Qiagen, Hilden, Germany) with a bead beater step in
advance, as previously described (31). The purified DNA was stored at 20°C
until use.
Real-time PCR assay conditions. Amplification and detection of purified bac-
terial DNA by real-time PCR was performed with the ABI228 Prism 7900 HT
from Applied Biosystems using optical grade 384-well plates. Each amplification
reaction was done in duplicate for each of the triplicate fecal and triplicate
fermentation samples in a final volume of 11 l containing 5.50 l EXPRESS
SYBR GreenER qPCR SuperMix (Invitrogen A/S, Taastrup, Denmark), 200 nM
each of the primers (Eurofins MWG Synthesis GmbH, Ebersberg, Germany), 2
l template DNA (5 ng/l), and nuclease-free water purified for PCR (Qiagen).
The amplification program consisted of one cycle at 50°C for 2 min, one cycle at
95°C for 10 min, 40 cycles at 95°C for 15 s and 60°C for 1 min, and finally one













cycle of melting curve analysis for amplicon specificity at 95°C for 15 s and 60°C
for 20 s, increasing the ramp rate by 1.92°C/min until maintaining at 95°C for 15 s.
The 16S rRNA-targeting primers used in this study are listed in Table 1. The
primers were tested to confirm sensitivity and specificity (see Table S1 in the
supplemental material).
Real-time PCR data handling. The relative quantities and relative ratios of
gene targets encoding 16S rRNA sequences of the bacterial taxa were calculated
using ECT and ECT (fermentation sample)/ECT (original bacterial community), respec-
tively, where E is the efficiency of the primer calculated from the slope of the
standard curve (E  101/slope) and CT is the CT value of the bacterial target
normalized against the CT value of the total bacterial population in the sample
(23). CT is the threshold cycle calculated by the ABI software (SDS version 2.2;
Applied Biosystems, Foster City, CA) as the PCR cycle, where the amplification
signal exceeds the selected threshold value, also set by the ABI software. Stan-
dard curves were created using serial 10-fold dilutions of bacterial DNA ex-
tracted from one of the fermentation samples for all primer sets. Analysis of the
standard curves allowed verification of PCR efficiency for the chosen PCR
conditions (Table 1). All results were calculated as the means of duplicate
determinations, equal values required.
Gas chromatography for SCFA analysis. Prior to quantification of SCFA, the
samples were acidified to pH 2 with 17% H3PO4 and centrifuged at 10,000 	
g for 10 min at room temperature to remove particle material. The supernatants
were collected and filtered through a 0.45-m-pore-size filter (Milipore, Copen-
hagen, Denmark) to remove bacterial cells. SCFA were analyzed using gas
chromatography (Perkin Elmer 400 Clarus) with a flame ionization detector and
a capillary column (Agilent Technologies, Horsholm, Denmark). The tempera-
tures of the injector and detector were 175°C and 200°C, respectively. The
temperature gradient was as follows: 70°C for 1 min, ramped at 8°C/min to
150°C, and after that ramped at 45°C/min to 230°C in 3 min (total time, 15.78
min). The injection volume of the sample was 0.5 l, and the nitrogen flow was
12 ml/min. The quantified SCFA were analyzed as acids: acetic, propionic, and
butyric. The standards used in the SCFA analysis were the same acids as men-
tioned above with concentrations of 1 to 40 m
.
Statistics. Statistical analysis of the quantitative real-time PCR (qPCR) data
was performed with the SAS JMP software (version 6.0.2; SAS Institute Inc.,
Cary, NC). Data were analyzed by a mixed-model analysis of variance
(ANOVA), where the microbiota source (healthy controls, UC patients in re-
mission, and UC patients in relapse) and the incubations (inoculum, FOS, and
AOS) were used as the fixed effects, while the individual subjects were entered
as random effects. When ANOVA indicated a significant difference, a pairwise
multiple comparison of means (Student’s t test) was used to determine significant
differences among treatment combinations, assuming equal variances. The PCR
measurements were log transformed before statistical analysis to obtain normal
distribution of the data. Normal distribution was assessed using a D’Agostino
and Pearson omnibus normality test with the GraphPad Prism software (version
5.03; GraphPad Software Inc., La Jolla, CA). Statistical analysis of the SCFA
data was performed with the SAS JMP software (version 6.0.2) using a two-way
ANOVA. Univariate ANOVA was used to analyze differences in the ages of the
three groups (GraphPad Prism software, version 5.03). Tests were considered
statistically significant if P values lower than 0.05 were obtained. Principal com-
ponent analysis (PCA) was carried out using the SAS JMP software (version
6.0.2) on the qPCR data to investigate the difference between the carbohydrate
incubations and, additionally, which bacterial taxa may be important for fermen-
tation of the tested carbohydrates.
RESULTS
Bacterial communities in the fecal samples. The relative
quantification of gene targets encoding 16S rRNA gene se-
quences present in the original bacterial communities derived
from fecal samples (Fig. 1) revealed that densities of Lactoba-
cillus spp. were significantly lower in the UC patients in relapse
than in healthy controls (P  0.05). No significant difference
between densities of Lactobacillus spp. present in UC patients
TABLE 1. 16S rRNA gene primers used in this study
Target taxon Primer Sequence (5–3) PCRproduct (bp)
Efficiency
(E)b Reference
Faecalibacterium prausnitzii Fprau 07 CCA TGA ATT GCC TTC AAA ACT GTT 140 1.90 64
Fprau 02 GAG CCT CAG CGT CAG TTG GT
Bifidobacterium spp. F-bifido CGC GTC YGG TGT GAA AG 244 2.04 9
R-bifido CCC CAC ATC CAG CAT CCA
Lactobacillus spp. Lacto-F AGC AGT AGG GAA TCT TCC A 341 1.98 22, 70
Lacto-R CAC CGC TAC ACA TGG AG
Clostridium leptum subgroup sg-Clept-F GCA CAA GCA GTG GAG T 239 2.03 38, 63
sg-Clept-R CTT CCT CCG TTT TGT CAA
Clostridium coccoides group g-Ccoc-F AAA TGA CGG TAC CTG ACT AA 440 2.02 38
g-Ccoc-R CTT TGA GTT TCA TTC TTG CGA A
Firmicutes phylum Firm934F GGA GYA TGT GGT TTA ATT CGA AGC A 126 2.01 20
Firm1060R AGC TGA CGA CAA CCA TGC AC
Bacteroidetes phylum Bact934F GGA RCA TGT GGT TTA ATT CGA TGA T 126 1.98 20
Bact1060R AGC TGA CGA CAA CCA TGC AG
Desulfovibrio spp. DSV691-F CCG TAG ATA TCT GGA GGA ACA TCA G 136 1.90 15
DSV826-R ACA TCT AGC ATC CAT CGT TTA CAG C
V2-V3 16S rRNA regiona HDA1 ACT CCT ACG GGA GGC AGC AGT 200 1.98 70
HDA2 GTA TTA CCG CGG CTG CTG GCA C
16S rRNA regiona TBA-F CGG CAA CGA GCG CAA CCC 130 2.04 10
TBA-R CCA TTG TAG CAC GTG TGT AGC C
a The HDA and TBA primers were used as total bacterial DNA targets to normalize for differences in total DNA concentrations between individual samples.
b Primer efficiency is calculated from the slope of the standard curve for each primer set, E  101/slope.













in remission and relapse, respectively, was observed. However,
there was a trend of lower densities of lactobacilli in the re-
lapse than in the remission group (0.05  P  0.10). Densities
of the Bacteroidetes phylum were significantly lower in the UC
patients in remission than in healthy controls (P  0.05). The
mean relative quantity of Bifidobacterium spp. was lower in the
UC patients in relapse than in the other groups, although this
was not statistically significant, probably due to high interindi-
vidual variation in the three groups. There were no significant
differences in the densities of the Firmicutes, the Clostridium coc-
coides group, the Clostridium leptum subgroup, Faecalibacterium
prausnitzii, and Desulfovibrio spp. between the three groups.
Changes in fecal microbial communities after in vitro fer-
mentation. After fermentation of FOS and AOS in fecal slur-
ries obtained from healthy subjects and UC patients in either
remission or relapse, qPCR was applied to measure the density
of gene targets encoding 16S rRNA genes of selected bacterial
taxonomic units (Fig. 2). In fecal communities derived from
healthy subjects and UC patients in remission, fermentation of
FOS resulted in a significant increase in the content of Bifido-
bacterium spp. (P  0.05). However, fermentation of AOS did
not similarly increase the proportion of bifidobacteria in these
samples, although a trend for higher levels of bifidobacteria in
the communities from healthy subjects was observed (P 
0.078). The communities derived from patients with UC in
relapse showed a significant increase in the density of bifido-
bacteria after fermentation with FOS as well as with AOS (P
0.05). The relative abundances of Lactobacillus spp. in fecal
microbiota derived from patients with UC in remission and
relapse were significantly increased after fermentation with
either FOS or AOS (P  0.05). The fecal communities from
healthy subjects contained a significantly higher density of lac-
tobacilli after fermentation with FOS (P 0.05). Although this
was only borderline significant for the samples fermented with
AOS, there was a strong trend of a similar effect (P  0.057).
A significant reduction of the Firmicutes phylum and of taxa
belonging to the Firmicutes (C. coccoides group, C. leptum
subgroup, and F. prausnitzii) was measured in all three fecal
microbiota groups after fermentation with AOS (P  0.05).
Firmicutes phylum levels in the samples fermented with FOS
were unaffected, although levels of the C. coccoides group, the
C. leptum subgroup, and F. prausnitzii were significantly re-
duced (P 0.05). FOS and AOS fermentation both resulted in
a decrease of the relative abundance of Bacteroidetes phylum
and Desulfovibrio spp. (genus belonging to the Proteobacteria
phylum) after fermentation of all three fecal microbiota groups
(P  0.05).
No significant differences between the effects of the two
carbohydrate sources AOS and FOS were observed, except in
the case of Bifidobacterium spp., which were more abundant
(P  0.05) in the samples from healthy subjects after incuba-
tion with FOS than in those incubated with AOS, and Desul-
fovibrio spp., where the density was significantly lower (P 
0.05) in the samples from UC patients in remission after incu-
bation with FOS than after incubation with AOS.
SCFA analysis and pH measurements after fermentation.
Amounts of SCFA (acetate, propionate, butyrate) produced by
fermentation of FOS and AOS and pH measurements are
shown in Table 2. For all types of samples (healthy, remission,
and relapse), the pH was lower in samples incubated with FOS
and AOS than in the samples incubated without added sub-
strate. The amount of acetate was significantly higher (P 
0.05) in all types of samples fermented with FOS than in the
samples with no substrate added. Additionally, acetate was
higher in samples from patients in relapse incubated with
AOS. A significantly lower (P  0.05) amount of propionate
was measured in samples from healthy subjects incubated with
FOS than in samples incubated with no substrate added. No
significant difference was observed in the amount of butyrate
after fermentation, independent of substrate and origin of the
microbial community.
Principal component analysis (PCA) of bacterial composi-
tion. The different bacterial taxonomic units as a function of
disease status and incubation with FOS or AOS were subjected
to PCA to generate an overview of the variation in the ability
of the microbial communities from either healthy subjects, UC
patients in remission, or UC patients in relapse to ferment the
two carbohydrate sources. Data were visualized in two dimen-
sions using a principal component score and loading plot (Fig.
3A and B, respectively). Two principal components were cal-
culated for the model with a total of 73.60% of variance ex-
pressed. The samples before (original bacterial communities)
and after incubation with or without either FOS or AOS for all
three stages of disease were clearly differentiated by the PC1,
with the fermented samples clustering to the left of the PCA
score plot (Fig. 3A). However, differentiation between samples
incubated with FOS and AOS was not seen. The loading plot
revealed that the primary bacterial taxa influencing the differ-
entiation between the original bacterial communities and sam-
ples incubated with added substrate were the Bifidobacterium
spp. and the Lactobacillus spp. (Fig. 3B).
FIG. 1. Relative quantities of gene targets of the original bacterial
community in fecal samples from healthy controls (white), ulcerative
colitis patients in remission (gray), and ulcerative colitis patients in
relapse (black). Target genes encoded 16S rRNA from Lactobacillus
spp., Bifidobacterium spp., Firmicutes, Bacteroidetes, Clostridium coc-
coides group, Clostridium leptum subgroup, Faecalibacterium praus-
nitzii, and Desulfovibrio spp. The relative quantities (RQ) were calcu-
lated as RQ ECT, where E represents the primer efficiency and CT
was the CT value of the bacterial target normalized against the CT
value of the total bacterial population in the sample. Total bacteria
were set to 100% (indicated by dotted line). Error bars represent
averages standard errors of the means of relative quantities in target
species in each of the six samples in each group. Asterisks indicate a
significant difference among groups (P  0.05).













FIG. 2. Relative ratios (RR) of target genes in samples incubated with FOS (white) and AOS (gray) compared to original bacterial commu-
nities, calculated as RR  ECT (fermentation samples)/ECT (original bacterial community). Original communities were set to 100% for each group (indicated
by dotted lines). Error bars represent averages  standard errors of the means of relative changes in target species in each of the six samples in
each group. Asterisks (*) indicate significant differences from the original bacterial communities, while pound signs (#) indicate significant
differences from FOS-fermented samples.














In this study, the mean relative quantity of Bifidobacterium
spp. in the original bacterial community was lower in UC
patients in relapse than in healthy controls (Fig. 1), but this was
not statistically significant. A previous study by Sokol and co-
workers (64) has shown significantly lower levels of Bifidobac-
terium spp. in fecal samples of UC patients. Additionally, Lac-
tobacillus spp. was significantly less abundant in the original
bacterial community of UC patients in relapse than in that of
healthy controls.
It should be acknowledged that differences between the mi-
crobial communities may partly be the consequence of the use
of anti-inflammatory drugs, since a recent study showed that
melsalazine affected the fecal bacterial community composi-
tion in patients with inflammatory bowel syndrome (2). In the
present study, four out of six UC patients in remission received
melsalazine, whereas all the UC patients in relapse received
the drug.
Fermentation of FOS resulted in significantly higher levels
of bifidobacteria in all types of microbial communities origi-
nating from either healthy subjects or UC patients. The bifi-
dogenic effect of FOS using fecal samples from healthy sub-
jects is in accordance with a number of previous in vitro studies
(24, 50, 55, 58). In contrast to these observations, a recent
study did not reveal any significant difference in the level of
bifidobacteria after incubation of fecal microbial communities
derived from healthy subjects with FOS and even demon-
strated a significant decrease in this bacterial group after FOS
incubation of fecal communities from patients with inactive
Crohn’s disease or active UC (49). The discrepancy in results
between the present study and the results reported by Rose
and coworkers (49) might be explained by the use of different
incubation methods. In the present study, a static batch system
was used for each individual fecal community, while Rose and
coworkers (49) pooled the individual fecal samples and used
the dynamic TIM-2 system. In agreement with the present
approach, many in vivo trials suggest a bifidogenic effect of
FOS in subjects with inflammatory bowel disease. A recent
trial using rats induced with colitis by 2,4,6-trinitrobenzenesul-
fonic acid (TNBS) showed that administration of FOS had an
anti-inflammatory effect and significantly increased concentra-
tions of bifidobacteria in cecum and colon (48). Additionally, a
small trial with patients suffering from active Crohn’s disease
showed that administration of FOS significantly increased the
mucosal and fecal counts of bifidobacteria. Furthermore, an
increase in the percentage of lamina propria dendritic cells
expressing the anti-inflammatory cytokine interleukin 10 (IL-
10) as well as a significant upregulation of expression of the
TABLE 2. pH measurements and short chain fatty acids liberated during fermentation
Parameter
Result for patient groupa
Healthy Remission Relapse
NS FOS AOS NS FOS AOS NS FOS AOS
pH rangeb 6.5–7.5 4.5–5.5 5–5.5 6.5–7.5 4.5–5.5 4.5–6 6.5–7.5 4.5–5.5 4.5–5.5
Total SCFA 36.34 ( 3.5) 40.97 ( 5.9) 33.77 ( 4.4) 24.53 ( 2.6) 32.79 ( 4.5) 22.35 ( 2.8) 14.95 ( 1.2) 28.95 ( 3.6) 21.25 ( 2.7)
Acetate 23.06A ( 2.7) 36.49B ( 5.8) 27.73A ( 3.3) 16.96A ( 2.0) 27.93B ( 1.9) 17.67A ( 1.8) 7.74A ( 2.1) 22.78B ( 4.6) 17.08B ( 1.6)
Propionate 5.91A ( 2.1) 1.61B ( 0.18) 2.54AB ( 1.1) 2.59 ( 0.82) 2.24 ( 1.1) 0.78 ( 0.16) 2.31 ( 0.7) 2.40 ( 0.9) 2.38 ( 1.5)
Butyrate 6.03 ( 1.5) 1.46 ( 0.41) 2.97 ( 2.4) 4.11 ( 1.2) 2.21 ( 0.9) 2.16 ( 1.5) 3.90 ( 1.5) 3.40 ( 1.8) 1.51 ( 1.0)
a NS, no substrate added; FOS, fructo-oligosaccharide; AOS, arabino-oligosaccharide. Total SCFA is acetate, butyrate, propionate, iso-butyrate, iso-valate, and
valate. All numbers are means of six samples  standard errors of the means and are expressed as nM. Unlike superscript letters are significantly different (P  0.05),
comparing each disease group.
b pH was measured using a pH indicator stick. Due to the uncertainty in the method, a range of pH for the different fermentations is used.
FIG. 3. Principal component analysis of the quantitative PCR measure-
ments using the first and second principal component (PC1, 54.94%; PC2,
18.66%). (A) Score plot showing the original bacterial communities (blue),
samples incubated with FOS (red) and samples incubated with AOS (green).
Sources of the communities are indicated by open circles (E) for healthy
subjects, closed circles (F) for UC patients in remission, and triangles () for
UC patients in relapse. (B) Loading plot, indicating each of the measured
bacterial taxa as determined by quantitative real-time PCR.













Toll-like receptors (TLRs) TLR2 and TLR4 was observed. The
authors of reference 32 suggest that this was caused by the
bifidogenic effect of FOS and that an increase of bifidobacteria
can act via TLRs or other pattern recognition receptors on
dendritic cells to stimulate IL-10 production.
Incubation with AOS gave rise to a significantly higher level
of bifidobacteria in fecal microbial communities derived from
UC patients in relapse, while no difference was seen after AOS
incubation of fecal communities from healthy subjects or UC
patients in remission. It was surprising to us that no statistically
significant increase of bifidobacteria upon AOS fermentation
by microbial communities derived from healthy subjects was
observed, since previous experiments from our lab have shown
that AOS caused a significantly higher level of bifidobacteria in
fecal microbial communities derived from healthy subjects
(24). However, there was a similar bifidogenic trend in the
present study (P  0.078), and we speculate that the lack of
significance is explained by a larger variation between the in-
dividual samples used. A previous in vitro fermentation study
using feces from healthy subjects reported that Bifidobacterium
spp. varied in their ability to hydrolyze arabino-oligosaccha-
rides and that they grew better on low-molecular-weight
fractions than on high-molecular-weight fractions of the oli-
gosaccharides (1). Genome sequencing has revealed that
carbohydrate-modifying enzymes can vary between species. Bi-
fidobacterium longum, Bifidobacterium adolescentis, Bifidobac-
terium animalis subsp. lactis, Bifidobacterium bifidum, Bifido-
bacterium pseudocatenulatum, and Bifidobacterium breve, which
are all commonly detected in human adult feces (67), have
genes encoding -fructofuranosidase and -L-arabinofuranosi-
dase, enabling the bacteria to utilize FOS and AOS, respec-
tively (UniProtKB database, http://www.uniprot.org/uniprot).
-L-Arabinofuranosidase catalyzes the hydrolysis of the glyco-
sidic bond between an arabinose moiety and the backbone, but
sequence analysis does not necessarily reveal if the specificity is
toward branched arabinan or arabinoxylan. However, B. breve
and B. bifidum do not harbor -L-arabinanase, which catalyzes
the hydrolysis of AOS backbone (UniProtKB database, http:
//www.uniprot.org/uniprot). However, it has been demon-
strated that B. adolescentis and B. longum are able to degrade
linear arabino-oligosaccharides (8 DP) to the same extent as
FOS, whereas B. breve is able only to hydrolyze FOS and B.
bifidum is not able to degrade either FOS or AOS. In the same
study, B. adolescentis utilized neutral oligosaccharides derived
from apple pectin (65). In another study, also based on pure
cultures, it was observed that B. breve, B. longum, and B.
adolescentis were able to partly ferment a mixture of linear
arabino-oligosaccharides (2 to 5 DP) derived from sugar beet
pectin; however, FOS was more efficiently fermented (68). The
observed differences in the response from the bifidobacterial
communities reported here may thus be explained by a differ-
ent intragenic composition of bifidobacteria in the individual
samples. Densities of lactobacilli in all fermentation samples
were significantly increased after incubation with FOS of mi-
crobial communities from healthy subjects and UC patients.
The same was seen after incubation with AOS, although it did
not reach statistical significance in healthy subjects (P 
0.057). The importance of the presence of Lactobacillus spp. in
the gut was previously highlighted by a study with IL-10-defi-
cient mice with colitis and reduced Lactobacillus spp. levels,
which showed that restoration of Lactobacillus spp. to a normal
level reduced the development of colitis (35). Additionally, a
human trial showed that ingestion of Lactobacillus GG aided
the maintenance of remission in patients with UC (72). Our in
vitro observations thus suggest that AOS as well as FOS con-
sumption might help patients suffering from UC by increasing
their levels of intestinal lactobacilli.
Bacteroidetes and Firmicutes (including C. coccoides group,
C. leptum subgroup, F. prausnitzii and Lactobacillus spp.) rep-
resent the two dominant bacterial phyla in the human gut and
together comprise about 90% of the large intestinal microbiota
(13, 45). A changed ratio between these groups has been sug-
gested to affect intestinal inflammation (64). In the present
study, no effect on the ratio between the Bacteroidetes and
Firmicutes was caused by incubation with either FOS or AOS.
Nevertheless, the relative quantity of members of the phylum
Bacteroidetes was significantly decreased in samples incubated
with FOS and AOS for all fecal communities tested, probably
due to the increase in bifidobacteria, which belong to the
phylum Actinobacteria. It may, however, be speculated that the
observed decrease was the result of the lower level of pH
observed after the 24 h of fermentation (Table 2) rather than
the inability of species of this phylum to utilize the carbohy-
drates, since responses to pH vary considerably between dif-
ferent phylogenetic groups of human colonic anaerobes and
variation in pH tolerance among the Bacteroidetes phylum has
been observed (12). However, in agreement with an effect of
the oligosaccharides added, Van Laere and coworkers (68)
demonstrated that several species of Bacteroides, including
Bacteroides vulgatus, Bacteroides ovatus, and Bacteroides
thetaiotaomicron, are not able to utilize a mixture of linear
arabino-oligosaccharides (2 to 5 DP) and can only partly de-
grade FOS. Additionally, pH-controlled in vitro studies also
have reported a significant decrease in the population size of
Bacteroides after incubation of FOS with fecal communities
from UC patients (49) and healthy subjects (36). Taken to-
gether, these findings indicate that even though the Bacterio-
detes phylum contains genera that can degrade and ferment a
wide variety of plant polysaccharides and oligosaccharides
(25), they may not be able to utilize FOS and AOS and hence
may not compete in the fermentor community when these are
the primary carbohydrate sources.
The butyrate-producing species F. prausnitzii and the bu-
tyrate-producing bacterial groups C. coccoides (cluster XIVa)
and C. leptum (cluster IV) are important for colonic health and
have an anti-inflammatory effect due to their production of
butyrate (34). However, in the present study their relative
abundance was decreased after incubation with FOS as well as
AOS in all three types of fecal communities. A similar effect of
FOS consumption on the abundance of the C. coccoides group
has been observed in mouse trials (44).
The relative density of Desulfovibrio spp. was significantly
decreased by incubation with FOS as well as AOS in all three
types of samples. Desulfovibrio spp. is the predominant sulfate-
reducing bacteria in the human colon, and the principal by-
product of sulfate-reducing bacteria is hydrogen sulfide (51).
The pH plays an important role for the growth of sulfate-
reducing bacteria and their production of hydrogen sulfate.
These bacteria prefer a growth environment that is neutral or
slightly alkaline (18), hence the low pH in the FOS- and AOS-













incubated samples is likely to have caused the relative decrease
of Desulfovibrio spp. A similar reduction in pH has been dem-
onstrated in the cecum and colon of animals given FOS com-
pared to control animals (6, 30, 48).
Sulfate-reducing bacteria have previously been linked to UC
development, because high concentrations of sulfides inhibit
butyrate metabolism in colonocytes and induce hyper-prolifer-
ation and metabolic abnormalities in epithelial cells, similar to
those observed with UC (7, 15). Additionally, Rowan and
coworkers (51) found that higher levels of Desulfovibrio spp.
were detected in the colonic mucus of patients with active UC
than in healthy controls, indicating a role of this bacterium in
the pathogenesis of UC. However, in the present study, no
significant difference in the abundance of Desulfovibrio spp.
was observed between the bacterial communities originating
from each of the three groups, which may be explained by the
use of fecal samples as opposed to mucosal samples (73). Still,
this does not exclude that a reduction in abundance of Desul-
fovibrio spp. as caused by FOS and AOS in the present study
may be beneficial in the prevention of colitis.
The SCFA profile reflects microbial activity (55). Acetate is
the predominant acid produced by bacterial fermentation in
fecal communities, and in consistence with the observed in-
crease in the acetate-producing bifidobacteria and lactobacilli,
our study revealed a significantly larger amount of acetate in
the samples incubated with either FOS or AOS. The higher
production of acetate may be the main cause of the observed
decrease in pH resulting from FOS and AOS fermentation.
Significantly lower levels of propionate were observed after
incubation of bacterial communities from healthy subjects with
FOS. Similar results have previously been reported by other
studies, where FOS fermentation resulted in lower levels of
propionate than other substrates, including, e.g., gentio-oligo-
saccharides (56) and AOS (1). One of the major intestinal
producers of propionate is Propionibacterium (19), and we
speculate that the population size of Propionibacterium species
may be higher (and more easily reduced after fermentation) in
healthy subjects than in UC patients, since no difference in
propionate level was observed after FOS incubation using fecal
samples from UC patients.
PCA of the qPCR data revealed that the bacterial groups
separating the fermented samples from the original bacterial
communities were Bifidobacterium spp. and Lactobacillus spp.,
which were both significantly more abundant in the microbiota
after fermentation of either FOS or AOS by communities
derived from UC patients (Fig. 2 and 3). Communities incu-
bated with FOS and AOS were not differentiated by the PCA
(Fig. 3), suggesting that these two oligosaccharides affected the
microbiotas similarly.
Our results suggest that the positive effects already observed
in human and animal trials using FOS may be applicable also
for AOS, which opens the possibility of exploration of, e.g.,
by-product streams of sugar production for prebiotic prepara-
tions. Hence, the presence and fermentation of AOS may help
prevent proinflammatory conditions and enhance the resis-
tance to colonization of opportunistic pathogens, e.g., through
increased production of acetate (17) and reduced pH in the
colonic environment. Considering the reduced levels of Lac-
tobacillus spp. and Bifidobacterium spp. present in UC patients
in relapse, a stimulation of these bacterial groups may prevent
flare-ups. However, human trials are needed to confirm a
health-promoting effect of AOS in UC patients.
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Feruloylated and Nonferuloylated Arabino-oligosaccharides from
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ABSTRACT: The side chains of the rhamnogalacturonan I fraction in sugar beet pectin are particularly rich in arabinan moieties,
which may be substituted with feruloyl groups. In this work the arabinan-rich fraction resulting from sugar beet pulp based pectin
production was separated by Amberlite XAD hydrophobic interaction and membrane separation into four fractions based on
feruloyl substitution and arabino-oligosaccharide chain length: short-chain (DP 210) and long-chain (DP 714) feruloylated and
nonferuloylated arabino-oligosaccharides, respectively. HPAEC, SEC, and MALDI-TOF/TOF analyses of the fractions conﬁrmed
the presence of singly and doubly substituted feruloylated arabino-oligosaccharides in the feruloyl-substituted fractions. In vitro
microbial fermentation by human fecal samples (n = 6 healthy human volunteers) showed a selective stimulation of biﬁdobacteria by
both the feruloylated and the nonferuloylated long-chain arabino-oligosaccharides to the same extent as the prebiotic fructo-
oligosaccharides control. None of the fractions stimulated the growth of the potential pathogen Clostridium diﬃcile in monocultures.
This work provides a ﬁrst report on the separation of potentially bioactive feruloylated arabino-oligosaccharides from sugar beet
pulp and an initial indication of the potentially larger biﬁdogenic eﬀect of relatively long-chain arabino-oligosaccharides as opposed
to short-chain arabino-oligosaccharides.
KEYWORDS: prebiotics, arabino-oligosaccharides, feruloyl substitution, hydrophilic interaction chromatography, Clostridium
diﬃcile
’ INTRODUCTION
Sugar beet pulp is a large side stream from the industrial
production of sugar. Currently, the main utilization of sugar beet
pulp is for cattle feed, but pectin can be extracted for a limited
number of applications. In sugar beet pectin the side chains of
rhamnogalacturonan I (RGI) are especially rich in arabinan
composed of R-(1,5)-linked backbones with a high degree of
R-(1,2) and/or R-(1,3) arabinofuranosyl substitutions1 along
with some β-(1,4)-linked galactan. The side chains of sugar beet
RGI can be feruloyl substituted either on O-2 in the main
backbone of R-(1,5)-linked arabinan, on O-5 in the terminal
arabinose,2 or on O-6 in the main backbone of galactan.3 The
content of ferulic acid can be up to 8.3 mg/g pectin.4 The feruloyl
substitutions can either be present as monomers or form
dimers with other side chains through oxidative coupling
reactions.5 Diferulic cross-linking plays an important role in
plant texture.6
Sugar beet pectin-derived arabino-oligosaccharides with DP
26 and DP < 8 have been reported to selectively stimulate
biﬁdobacteria over clostridia, lactobacilli, and bacteroides in in
vitro fecal fermentations.7,8 Moreover, in single-culture studies it
has been shown that linear arabino-oligosaccharides may be
utilized by Biﬁdobacterium adolescentis, Biﬁdobacterium longum,
and Bacteroides vulgatus, but not by other biﬁdobacteria or the
tested lactobacilli.9
The biological eﬀect of oligosaccharide feruloyl substitu-
tion on gut microbiota has so far mainly been investigated for
arabino-xylo-oligosaccharides. Feruloylated arabino-xylo-oligo-
saccharides were shown to stimulate the growth of Biﬁdobacter-
ium biﬁdum in a single-culture study,10 xylo-feruloyl-arabinose
from grass cell walls has been reported to be metabolized by rat
gut microbiota,11 and recently ferulic acid was found to be
released from durum wheat oligosaccharides during digestion
by human intestinal microbiota.12 Moderate feruloyl substitution
was shown not to impede the degradation of maize cell wall by
human intestinal microbiota.13
Probiotic bacteria such as biﬁdobacteria and lactobacilli
have been shown to be able to speciﬁcally express feruloyl
esterase activity in the presence of feruloylated substrates.
Biﬁdobacterium sp., including B. longum, thus express feruloyl
esterase activity in the presence of wheat bran, rye bran, barley
spent grain, and larchwood arabinogalactan,14 and Lactobacillus
acidophilus expresses feruloyl esterase activity in the presence of
destarched wheat bran.15 These studies on arabinoxylan-derived
oligosaccharides are not directly comparable to feruloyl-substituted
arabino-oligosaccharides, because feruloyl substitution in
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arabinoxylan is O-5 linked and feruloyl substitutions in arabino-
oligosaccharides are mainly O-2 linked. Therefore, these two
types of feruloyl-substituted substrates require diﬀerent types of
feruloyl esterases for enzyme-catalyzed ferulic acid removal. It is
known that type B feruloyl esterases are active on pectin-derived
substrates,16 but little has been reported with respect to biﬁdogenic
or other prebiotic eﬀects of pectin-derived O-2 ferulic acid
arabinose conjugates. We hypothesized that O-2 feruloyl substi-
tutions on arabino-oligosaccharides derived from sugar beet
pectin might exhibit prebiotic eﬀects and, secondly, that the
arabino-oligosaccharide backbone chain length might inﬂuence
the outcome. The purpose of the present study was therefore to
ﬁrst prepare fractions of diﬀerent arabino-oligosaccharide chain
lengths enriched in feruloyl substitutions, and the corresponding
nonferulated counterparts, both from sugar beet pectin and then
to evaluate the in vitro fermentability of the fractions by human
intestinal microbiota.
’MATERIALS AND METHODS
Substrate. Sugar beet arabino-oligosaccharides were obtained from
Danisco A/S (Nakskov, Denmark). These arabino-oligosaccharides,
in the following referred to as “starting material”, were supplied as a
liquid side stream from the ultrafiltration and diafiltration step in the
sequential acid extraction of pectin with nitric acid from sugar beet pulp,
involving removal of insoluble cellulose, ultrafiltration, and diafiltration
with a 50 kDa cutoff.4
Chemicals. Ferulic acid, cinnamic acid, sodium hydroxide, sodium
acetate, D-glucuronic acid, D-galactose, D-arabinose, D-fucose, L-rhamnose
monohydrate, D-galacturonic acid monohydrate, and 2,5-dihydroxy-
benzoic acid were obtained from Sigma-Aldrich (Steinheim, Germany).
D-Glucose and D-xylose were obtained fromMerck (Darmstadt, Germany).
Trifluoroacetic acid was from Riedel-deHa€en (Seelze, Germany). Arabino-
oligosaccharide standards with DP from 2 to 5 were obtained from
Megazyme (Bray, Co. Wicklow, Ireland). Acetonitrile was obtained from
LGC Promochem (Middlesex, U.K.). Amberlite XAD-2 was obtained from
Rohm andHaas Denmark (Copenhagen, Denmark). Fructo-oligosaccharides
(FOS) (DP 28; OraftiP95) were obtained from Beneo-Orafti (Tienen,
Belgium).
XAD Separation. XAD separation was performed at room tempera-
ture in a 200 mL stirred membrane reactor model 8200 (Millipore,
Billerica, MA) equipped with a 100 kDa regenerated cellulose mem-
brane (Millipore), connected to compressed nitrogen for flux regulation.
The reactor contents were mixed by magnetic stirring. The starting
material was added to the XADmaterial (washed in 2 volumes of ethanol
and 2 volumes of water prior to use) in a 1:1 volume ratio. The suspension
was stirred for 1 h, and unbound material was then removed by filtration.
In each round, the contact time between the eluent and the XAD was 30
min before filtration. Putative nonferuloylated arabino-oligosaccharides
(denoted AOS) were eluted in 4 sample volumes of water, and feruloy-
lated arabino-oligosaccharides (denoted FAOS) were eluted in 5 sample
volumes of methanol/water 1:1 (v/v). The methanol/water fraction was
dried on a rotary evaporator and resolubilized in deionized water. The
AOS and FAOS fractions were subsequently separated according to
molecular weight (see below). Residual material was eluted in 3 sample
volumes of 100% methanol. This fraction was not used further.
Membrane Separation. Separation according to size for both the
AOS fraction and the FAOS fraction was performed in a 200 mL stirred
membrane reactor model 8200 (Millipore) equipped with a 1 kDa
MWCO regenerated cellulose membrane (Millipore), connected to
compressed nitrogen for flux regulation. The reactor contents were
mixed by magnetic stirring using an RCT basic magnetic stirrer (IKA,
Germany). The temperature was maintained at 45 C. Filtration was
performed until the retentate volume was 10% of the sample volume,
followed by diafiltration in 1 sample volume of deionized water. After
ultra- and diafiltration, all permeates and retentates were concentrated
on a rotary evaporator, lyophilized, resolubilized in water, and stored at
4 C until further use. The permeates enriched in low molecular weight
(small) oligosaccharides were denoted SAOS and SFAOS, respectively,
and the retentates enriched in high molecular weight (long) oligosac-
charides were denoted LAOS and LFAOS, respectively.
Acid Hydrolysis. The monosaccharide composition of all fractions
was determined by acid hydrolysis with 2 g/L substrate concentration
and 2 M trifluoroacetic acid at 121 C for 2 h followed by lyophilization
and resolubilization in deionized water, and the recovery of monosac-
charides was determined by performing the same hydrolysis on D-fucose,
L-rhamnose, D-arabinose, D-galactose, D-glucose, D-xylose, D-galacturonic
acid, and D-glucuronic acid.17 Relative standard deviation values for all
measurements were determined for at least three measurements and
ranged from 0.5 to 10%.
Ionic ExchangeChromatography (HPAEC).Monosaccharide
composition and AOS concentrations were analyzed by high-
performance anion exchange chromatography with pulsed amperometric
detection (HPAEC-PAD) using a Dionex BioLC system (Dionex Corp.,
Sunnyvale, CA) equipped with a Dionex CarboPac PA1 analytical
column (4  250 mm). For analysis of monosaccharides a two-eluent
system comprising deionized water and a 500 mM NaOH aqueous
solution was used. The monosaccharides were separated by isocratic
elution with 25 mM NaOH for 4 min, 10 mM NaOH for 14 min, and
500 mM NaOH for 12 min, followed by regeneration with 25 mM
NaOH for 5 min. For analysis of oligosaccharides, a three-eluent system
comprising deionized water, a 500 mM NaOH aqueous solution, and a
500mMsodium acetate aqueous solutionwas used (modified from ref 18).
AOS were eluted isocratically with 25 mMNaOAc for 5 min followed by
a linear gradient from 25 to 400 mM NaOAc for 20 min and then
isocratically with 400mMNaOAc for 10min. The NaOH concentration
was maintained at 100 mM throughout the run. The eluent flow was
always kept at 1.0 mL/min. Quantification was carried out using external
monosaccharide standards: D-fucose, L-rhamnose, D-arabinose, D-galactose,
D-glucose, D-xylose, and D-galacturonic acid or di-, tri-, tetra-, and penta-
mers of arabino-oligosaccharides. Amounts were expressed as milligrams
per gram of drymatter (mg/g) ormole percentage (mol%). The following
pulse potentials and durations were used for detection: E1 = 0.1 V, t1 =
400ms; E2 =2 V, t2 = 20ms; E3 = 0.6 V, m3 =10ms; E4 =0.1 V, t4 =
60 ms. Data were collected and analyzed with the program Chromeleon
6.80 SP4 Build 2361 software (Dionex Corp., Sunnyvale, CA).
Size Exclusion Chromatography.HPSEC was performed using
a P680 HPLC pump, an ASI-100 automated sample injector, and an
RI-101 refractive index detector (Dionex). Samples were separated on a
Shodex SB-806HQGPC column (300  8 mm) with a Shodex SB-G
guard column (50  6 mm) from Showa Denko K.K. (Tokyo, Japan)
with 100 mM sodium acetate, pH 6, as mobile phase at a flow rate of
0.5 mL/min; the temperature was maintained at 40 C. Prior to
injection, the sample was diluted in 100 mM sodium acetate to avoid
large buffer peaks.19
Phenolics Analysis. Ferulic acid was released from arabinan
structures by saponification by adding NaOH to a final concentration
of 1 M followed by incubation at room temperature for 1 h. Subse-
quently, the pH was adjusted to <3 by adding HCl. Ferulic acid and
vanillin were analyzed using RP-HPLC with DAD, Chemstation 1100
series, Hewlett-Packard, and an ODS-L Optimal (250 4.6 mm, 5 μm)
column from Capital HPLC. The chromatographic profile consisted of
buffer A (5% acetonitrile, 1 mMTFA) and acetonitrile starting with 20%
acetonitrile. Running gradient was up to 40% acetonitrile for 35 min and
further up to 100% for another 3 min, followed by regeneration to 20%
acetonitrile for 2 min. Column temperature was maintained at 40 C.20
The amount of trans-ferulic acid was detected and quantified at 316 nm
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using an authentic external standard and expressed as micromoles per
gram of dry matter (μmol/g). cis-Ferulic acid and vanillin were detected
and recognized at 316 nm but quantified at 280 nm according to
response factors as described by Waldron et al.21
HILIC Chromatography. Separation of feruloylated AOS based
on hydrophilic interaction was performed using an
::
AKTA purifier 100
workstation equipped with a UV-900 monitor, a pH/C monitor, and
a Frac-950 fraction collector, equipped with an TSK-GEL Amide-80
column (250 4.6 mm i.d., 5 μm, Tosoh Bioscience), all controlled by
UNICORN software. The temperature was maintained at 55 C using
a Thermasphere HPLC column heater/chiller (Phenomenex). The
elution system consisted of acetonitrile and deionized water. The column
was equilibrated with 80% acetonitrile for 2 column volumes (CV),
isocratic elution at 80% for 2 CV, followed by a linear gradient at 2%
acetonitrile/CV. Feruloylated compounds were detected and quantified by
UV absorption at 316 nm using ferulic acid as external standard. Prior to
injection, the sample was adjusted to 80% acetonitrile, centrifuged briefly
for removal of precipitate, and filtered through a 0.22 μm nylon filter.
Mass Spectrometry. One microliter of sample followed by 0.5 μL
of matrix solution (20 mg/mL 2,5-dihydroxybenzoic acid 70% acetoni-
trile and 0.1% trifluoroacetic acid/water) was added to anOpti-TOF 384
well plate. For fast crystallization, the sample was dried under a lamp and
an additional 0.5 μL of matrix solution added. The samples were
analyzed on a 4800 Plus MALDI TOF/TOF (AB Sciex) mass spectro-
meter. The instrument was operated in reflectron, positive ion mode.
Acceleration voltage was 20 kV. Depending on the sample analyzed,
laser intensity and number of laser shots were varied to obtain optimal
spectra. The mass range was set to 1003500 Da. For all MS/MS data,
air was used as collision gas. The MS and MS/MS data were exported as
a text file using DataExplorer (version 4.6), and each spectrum was
smoothed, labeled, and analyzed manually employing M/Z (Genomic
Solutions). For annotation of MS/MS spectra, the nomenclature
suggested by Doman and Costello22 was applied.
Subjects and Fecal Samples. Fecal samples were obtained from
six healthy volunteers (mean age = 40.7 ( 8.5 years). None of the
participants had been treated with antibiotics for at least 3months before
participation and had no history of gastrointestinal disorder. Whole
stools were collected in airtight containers, immediately stored at 4 C,
and processed within 12 h. Feces (200mgwet weight) were collected for
DNA extraction, and additional fecal samples for in vitro fermentation
were prepared by homogenization in 50% glycerol (1:1 dilution in
deionized water) in an anaerobic cabinet (containing 10%H2, 10%CO2,
and 80% N2) and stored at 80 C until further analysis.
In Vitro Fermentation. A small-scale in vitro fermentation
method was used to assess the fermentability of the oligosaccharides
on human fecal samples principally as reported previously.23 FOS was
applied as a standard with known bifidogenic effect. Oligosaccharides or
FOS were added to an autoclaved minimal basal medium to give a final
concentration of 5 g (dry matter)/L in a reaction volume of 2 mL. The
solutions were reduced in an anaerobic cabinet overnight. The minimal
basal medium contained, per liter, 2 g of peptone water, 1 g of yeast
extract, 0.1 g of NaCl, 0.04 g of K2HPO4, 0.04 g of KH2PO4, 0.01 g of
MgSO4 3 7H2O, 0.01 g of CaCl2 3 2H2O, 2 g of NaHCO3, 0.5 g of bile
salts, 0.5 g of L-cysteine hydrochloride, 0.005 g of hemin, 10 μL of
vitamin K1 (0.02 mM), 2 mL of Tween 80, and 1 mL of 0.05% (w/v)
resazurin solution. A 10% (w/v) fecal slurry was prepared by mixing the
feces stored in 50% glycerol with degassed PBS. The reduced minimal
medium samples with added oligosaccharides were inoculated at a final
concentration of 1% (w/v) feces. Each fermentation experiment for the
fecal sample of each healthy volunteer was carried out in triplicate to
give 6  3 fermentations that were incubated at 37 C for 24 h in an
anaerobic cabinet.
Extraction of Bacterial DNA. DNA was extracted from fecal and
fermentation samples using the QIAamp Stool DNA Mini Kit (Qiagen,
Hilden, Germany) with a bead-beater step in advance, as described by
Leser et al.24 The purified DNA was stored at 20 C until use.
Real-Time PCR Assay Conditions. Amplification and detection
of purified bacterial DNA by real-time PCR were performed with the
ABI-Prism 7900 HT from Applied Biosystems using optical grade
384-well plates. Primers specifically targeting 16S rRNA gene sequences
of the Bacteroidetes and Firmicutes phyla and the Lactobacillus and
Bifidobacterium genera were included in the qPCR analysis (Table 1).
The amplification reactions were carried out in a total volume of 11 μL
containing 50 μL of EXPRESS SYBR GreenER qPCR SuperMix
(Invitrogen A/S, Taastrup, Denmark), 400 nM of each of the primers
(Eurofins MWG Synthesis GmbH, Ebersberg, Germany), 2 μL of
template DNA, and nuclease-free water (Qiagen) purified for PCR. The
amplification program consisted of one cycle at 50 C for 2min; one cycle at
95 C for 10min; 40 cycles at 95 C for 15 s and 60 C for 1min; and finally
one cycle of melting curve analysis for amplicon specificity at 95 C for 15 s
and 60 C for 20 s with increasing ramp rate by 2% until 95 C for 15 s.
Real-Time PCR Data Handling. The relative quantity of gene
targets encoding 16S rRNA of the bacterial taxa were calculated using
the approximation 2Ct. Ct is the threshold cycle calculated by the ABI
software as the PCR cycle, where the amplifications signal exceeds the
selected threshold value, also set by the software. The amounts of
bacterial specific DNA targets were normalized to total bacteria DNA
targets to correct for differences in total DNA concentration between
individual samples. Standard curves were created using serial 10-fold
dilutions of bacterial DNA extracted from one of the fermentation
samples for all primer sets. Analysis of the standard curves allowed
verification of PCR efficiency for the chosen PCR conditions (Table 1).
All results were calculated as means of duplicate determinations.
Table 1. 16S rRNA Primers for Real Time PCR
target gene forward primer (5030) reverse primer (5030) eﬃciency (%) ref
Biﬁdobacterium spp. cgc gtc ygg tgt gaa ag ccc cac atc cag cat cca 101 32
Lactobacillus spp. agc agt agg gaa tct tcc a cac cgc tac aca tgg ag 95 33, 34
Firmicutes phylum gga gya tgt ggt tta att cga agc a agc tga cga caa cca tgc ac 99 35
Bacteroidetes phylum gga rca tgt ggt tta att cga tga t agc tga cga caa cca tgc ag 100 35
total bacteria act cct acg gga ggc agc agt gta tta ccg cgg ctg ctg gca c 101 34








starting material 100.0 36.2 100.0
unbound 47.9 6.1 8.1
water 28.7 0.7 0.5
MeOH/water 21.3 143.9 84.8
MeOH 1.8 12.0 0.6
loss 0.4 6.1
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Statistics. Statistical analysis was performed using GraphPad
PRISM v5.03. One-way ANOVA and Tukey’s multiple-comparison test
were used to determine significant differences among bacteria popula-
tions for the in vitro fermentation. The quantitative PCR measurements
were log-transformed before statistical analysis to obtain normal distri-
bution of the data. Tests were considered to be statistically significant if P
values lower than 0.05 were obtained.
Bioscreen. The ability of the different fractions to function as a sole
carbon source for the potential pathogen Clostridium difficile was
assessed in a pure culture fermentation study. C. difficile was obtained
from Deutche Sammlung Microorganismes and grown in reinforced
clostridial media for preculturing and tryptic soy broth without dextrose
(both from Bacto, BD, Franklin Lakes, NJ) for the experiment. Bacterial
growth in a 1% w/v substrate solution was measured with the automatic
Bioscreen C system as described by M€akel€ainen et al.25 and measured as
the area under the growth curve (OD600  min) obtained from the
Bioscreen data. This method also takes the speed of growth initiation
into account, compared to just evaluating the end absorbance.
’RESULTS AND DISCUSSION
Separation Based on Feruloyl Substitution. The original
starting material, which comprised a ferulic acid content of
36 μmol/g (Table 2), was separated into feruloylated (FAOS)
and nonferuloylated (AOS) oligosaccharides by the XAD separa-
tion. The unbound fraction (representing the part of the starting
material unable to bind to the XADmaterial) represented 48% of
total sample load and had a ferulic acid concentration of 6 μmol/g.
The recovered water fraction, containing the AOS fraction,
accounted for 29% of total sample load and had a ferulic acid
concentration of 0.7 μmol/g, whereas 21%of total sample loadwas
found in the MeOH/water fraction, which had a ferulic acid
concentration of 144 μmol/g. TheMeOH/water fraction accounted
for 85% of the total ferulic acid load, and thus contained the FAOS
fraction. The remaining 2% of sample load was found in the MeOH
fraction with a ferulic acid concentration of 12 μmol/g and trace
amounts of vanillin.No further analysis of this fractionwas conducted.
Separation Based on Molecular Weight. The AOS and
FAOS fractions were both separated according to size and
subsequently analyzed with respect to average molecular weight,
content of monosaccharides and short oligosaccharides, mono-
saccharide composition, and ferulic acid content. Size exclusion
chromatography (Figure 1) showed the original starting material
to have a dual distribution, with one peak at 25 min correspond-
ing to monomers and a larger broader peak around 1.0 kDa. For
the nonferulated fractions (Figure 1A) LAOS showed one
homogeneous peak above 1.0 kDa and SAOS showed two peaks,
both below 1.0 kDa. For the feruloylated fractions, the larger
fraction LFAOS had a shape and size similar to those of LAOS,
whereas SFAOS showed a broader distribution and had only
a shoulder that corresponds to the presence of lower amounts of
monomers, compared to the starting material (Figure 1B).
Carbohydrate Composition. The starting material and the
four final fractions, SAOS, LAOS, SFAOS, and LFAOS, were
investigated with respect to content of monosaccharides, shorter
linear arabino-oligosaccharides, and monosaccharide composi-
tion using HPAEC directly on the fractions and on fractions
subjected to acid hydrolysis. HPAEC analysis of the original
starting material showed that approximately 125 mg/g was
monosaccharides (mainly arabinose, glucose, and fructose) and
18mg/g wasmade up of linearR-1,5 arabinooligosaccharides DP
25. For SAOS the amount of monosaccharides was 15 mg/g,
and linear arabinooligosaccharides constituted 17 mg/g. For
LAOS, SFAOS, and LFAOS the amounts of monosaccharides
were significantly lower. These results indicated that the majority
of monomers did not bind to the XAD and therefore could be
assumed to be in the unbound fraction.
Figure 1. Size exclusion chromatography SAOS and LAOS (A) and SFAOS and LFAOS (B), both in comparison with the original starting material,
arabinose, and 1.3 kDa pullanan standard.
Figure 2. HPAEC elution proﬁles with electrochemical detection.
Elution of monomers is not shown. Linear R-1,5 arabinooligosacchar-
ides DP 25 are marked.
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HPAEC (Figure 2) revealed pairs of peaks, which may be
indicative of branched arabino-oligosaccharides because
branched arabino-oligosaccharides do not coelute with linear
arabino-oligosaccharides.26 HPAEC of SFAOS showed elution
of a broad peak with a retention time comparable to that of
monomers, but no identiﬁcation was possible (Figure 3). The
broad peak with heavy tailing indicated coelution of various
smaller compounds, presumably feruloylated arabinose and
arabinobiose. The monosaccharide analysis after acid hydrolysis
revealed that besides at least 80% AOS, all of the samples
contained traces of galactose, rhamnose, and galacturonic acid
normally found in RGI (Table 3). Glucose was found mainly in
the SAOS fraction. Fucose, xylose, and glucuronic acid were
detected in the starting material and the high molecular weight
fractions (LAOS and LFAOS) in trace amounts (<0.1 mol %,
data not shown). The presence of these sugars could indicate the
presence of trace amounts of RGII and/or xyloglucan.
Ferulic Acid Distribution. Analysis of the trans-ferulic acid
content of each fraction revealed that the ferulic acid present in
the water fraction from XAD separation, after the membrane
separation, primarily was found in the high molecular fraction,
whereas the distribution of ferulic acid in the SFAOS and LFAOS
fractions was in the same order of magnitude (Table 3). Besides
trans-ferulic acid, minor amounts of cis-ferulic acid were found in
the range of 0.22.8 μmol/g in all fractions. Also, minor
amounts of vanillin were detected, mainly in the SFAOS fraction.
Feruloylated arabino-oligosaccharides SFAOS and LFAOS
were further analyzed using hydrophilic separation (Figure 4).
Each peak was collected and analyzed by MALDI-TOF and
TOF/TOF. Series of arabino-oligosaccharides with a single
feruloyl substitution with DP 210 and series with double
feruloyl substitutions DP 714 were detected (Table 4). No
ferulic dimers were detected in the analyzed fractions, even
though reverse phase analysis indicated the presence of putative
dimers (data not shown). No feruloyl substitutions on galactose
residues were detected. MS/MS analysis conﬁrmed the presence of
monosubstituted and double-substituted arabino-oligosaccharides,
but MS/MS data did not give suﬃcient results for complete
determination of the degree of branching or the exact point of
feruloyl substitution on each type of molecule, because mol-
ecules with diﬀerent substitution patterns would have the same
fragmentation pattern. As exempliﬁed by MS/MS fragmentation
of a single feruloylated DP 5 (Figure 5) from fraction V (Figure 4;
Table 4), at least two diﬀerent molecules were present in the
fraction. In the fragmentation nomenclature the suﬃx “F”
describes whether a feruloyl substitution is present on the ion
or not. Arabinose moieties are numbered from the reducing end.
Because MS/MS analysis was performed in positive mode,
sodium adducts were formed. The fragmentation pattern lacked
any trace of ferulated Y1, Z1, and X0 ions, indicating that
feruloyl substitution did not occur at the reducing end. The
presence of both feruloylated and nonferuloylated Y2 and
1,4X2
ions (m/z 481, 509, 305, and 333, respectively) indicated that
feruloyl substitution occurred at arabinose 2 in one of the
molecule types. The presence of 1,4X4F (m/z 773) would
indicate that no O-2 or O-3 feruloyl substitutions were present
at the nonreducing end, but the presence of 0,3X4 (m/z 641)
indicated feruloyl substitution at O-5 at the nonreducing end. It
was not possible to obtain ions conﬁrming any feruloyl substitu-
tion at arabinose 3 or 4. The fragmentation pattern thus clearly
indicated the presence of at least two diﬀerent molecules, one
type with feruloyl substitution at the O-5 at the nonreducing end
and one type with feruloyl substitution at O-2 at arabinose 2.
For simplicity, only linear structures were considered, and the
presumably branched nature of sugar beet arabinan is not
considered. Besides arabino-oligosaccharides singly substituted
with ferulic acid, also arabino-oligosaccharides doubly substi-
tuted with ferulic acid were observed. The exact structures could
not be elucidated by MS/MS due to an even higher complexity
and diversity than the singly substituted arabino-oligosaccharides
(data not shown).
The sample preparation prior to HILIC separation might have
favored the recovery of lower DPs, because the adjustment of
acetonitrile concentration to 80% caused some of the sample to
precipitate. MALDI-TOF analysis of the SFAOS and LFAOS
precipitates showed traces of feruloylated arabino-oligosacchar-
ides with sizes up toDP 22 and 30, respectively (data not shown).
Still, the HILIC separation gave information about the relative
abundance of each size of oligomers based on the area of each
peak. SFAOS consisted mainly of oligosaccharides with DP
15, whereas LFAOS had a broader distribution, with some
oligosaccharides below 1 kDa being present based on both
HPSEC and HILIC data.
Figure 3. HPAEC elution proﬁle of SFAOS with electrochemical
detection. Arabinose and linear R-1,5 arabinooligosaccharides DP
23 are marked.
Table 3. Mass Distribution, Ferulic Acid Content, and Monosaccharide Composition of Fractions from Membrane Separation
mol %
mass distribution (mg/g starting material) ferulic acid content (μmol/g) rhamnose arabinose galactose glucose galA fructose
starting material 1000 36.2 1.13 85.16 1.95 6.78 1.63 2.77
SAOS 196.9 1.7 1.75 82.15 1.62 13.18 0.70 0.61
LAOS 40.1 66.0 0.99 86.68 3.44 0.75 7.07 0.09
SFAOS 67.2 186.5 1.47 92.63 3.14 0.69 1.17 0.25
LFAOS 148.7 247.3 0.72 95.98 1.77 0.29 0.82 0.00
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The HILIC separation method is capable of detection of
ferulated arabino-oligosaccharides from DP 1 to at least DP
1520. Analysis of LAOS did not show anymolecules within this
size frame (data not shown), despite this fraction containing
signiﬁcant amounts of ferulic acid (Table 3). According to the
HPAEC analysis, LAOS did contain oligosaccharides with an
approximate size of DP 510, but apparently the feruloyl
substitution was present on oligosaccharides with higher DP than
DP 20. (The term “oligosaccharides” is used for consistency.) The
fact that only the relatively larger oligosaccharides were feruloyl
substituted justiﬁes the appearance of ferulated molecules in the
water fraction, because the overall hydrophilicity of, for example,
an arabino-oligosaccharide with DP 20 and a single feruloyl
substitution would still fractionate into the water fraction.
In Vitro Fermentation. Quantitative real-time PCR from in
vitro fermentations showed that fermentation on SAOS, LAOS,
LFAOS, and the starting material selectively increased the
density of Bifidobacterium spp. significantly (P < 0.05, P < 0.01
P < 0.001, and P < 0.05, respectively) when compared to the
original fecal sample (Figure 6). The densities of bifidobacteria
after fermentation of the high molecular weight fractions, LAOS
and LFAOS, were not significantly different from the densities
obtained by fermentation of FOS, which is considered to be the
“golden standard” within the field of prebiotics. This result con-
firmed that the induced growth was due to the arabino-oligosac-
charides and not a result of the presence of monomers. The finding
that arabino-oligosaccharides are bifidogenic is in agreement with a
recently patented discovery stating that branched arabino-oligo-
saccharides with DP 215 are bifidogenic.27 However, the
patent27 stated that sugar beet derived arabinose-rich pectin
oligosaccharides do not exert prebiotic effects in vitro. This
statement may be due to the fact that mainly homogalacturonan
sugar beet pectin oligosaccharides were evaluated in the patent as
opposed to the arabino-oligosaccharides described in the present
work, which consisted of only 17% galacturonic acid and
8796% arabinose (Table 3). Fermentation of the LAOS and
LFAOS fractions did not yield significantly different results,
indicating that the size of the oligosaccharides was more im-
portant for selective bacterial stimulation than the amount of
feruloyl substitutions. The findings that the high molecular
weight fractions were more bifidogenic than the low molecular
weight fractions further elaborates on the findings reported by
Al-Tamimi et al.8 which indicated that the low molecular weight
fractions were more selective for bifidobacteria than arabinan. In
that study8 only arabino-oligosaccharides up to DP 8 were tested,
and some fractions appeared to containmainly monosaccharides.
The fact that feruloyl substitution was no hindrance to bifido-
genic metabolism was in good correlation with the results by
Funk et al.13 They found that human intestinal microbial
communities were able to degrade maize cell wall material
regardless of ferulate levels.
No signiﬁcant changes were seen in the densities of Lactoba-
cillus spp. and Firmicutes after fermentation. The relative amount
of Bacteroidetes decreased signiﬁcantly (P < 0.001) for all tested
fractions, including FOS, as compared to the inoculum
(Figure 6). This decrease was most likely due to an increase in
other types of bacteria. The relative balance between Firmicutes
and Bacteroidetes is believed to play a role in obesity risk, both
with respect to developing obesity as shown by introducing
“obese microbiota” in germ-free mice28 and by the observation
that the relative levels of Firmicutes and Bacteroidetes change,
that is, the relative levels of Bacteroidetes increase even though
the levels of Firmicutes are still dominant, when the diet for obese
humans is restricted.29 In the study presented in this paper the
relative level of Firmicutes remained unchanged and the relative
level of Bacteroidetes decreased signiﬁcantly, thereby altering
the relative balance toward a higher Firmicutes/Bacteroidetes ratio.
These data suggest that all of the oligosaccharide fractions,
including FOS, a commercial prebiotic, may increase the risk
of obesity and maybe, in turn, the risk of developing the
metabolic syndrome associated with obesity. However, it is not
clear if the extent of change observed after the in vitro fermenta-
tions has any signiﬁcance, as the available in vivo evidence of an
eﬀect of change in the Firmicutes/Bacteroidetes ratio was recorded
over a longer period, namely 1 year, and the change was
accompanied by a change in body weight (in humans).29 Clearly,
the data therefore require further investigation.
Besides the positive biﬁdogenic eﬀects of the feruloylated
arabino-oligosaccharides, it was investigated whether these sub-
strates could be fermented by an opportunistic intestinal pathogen,
C. diﬃcile.C. diﬃcile infection is linked to consumption of antibiotics,
which disrupt the normal intestinal microbiota, allowing C. diﬃcile








VII DP6, DP7 DP9
VIII DP7, DP8 DP10
IX DP8, DP9 DP11, DP12
X DP9, DP10 DP13, DP14
aUnderscore indicates the mass with highest intensity in the MALDI-
TOF analysis (MALDI-TOF data not shown).
Figure 4. HILIC separation proﬁle with UV detection at 316 nm. For
peak identities refer to Table 4.
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Figure 6. Relative quantities of target genes in samples from original fecal bacterial communities and after fermentation of oligosaccharides by
these communities. Target genes encoded 16S rRNA from Biﬁdobacterium spp., Lactobacillus spp., Bacteroidetes, and Firmicutes. Fecal samples were
obtained from the six healthy volunteers. The bars represent the average ( SEM of the response from six volunteers. Asterisks indicate a signiﬁcant
diﬀerence between target density in the original community and in the fermented samples: P < 0.05, /; P < 0.01, //; P < 0.001, ///. Pound signs indicate
a signiﬁcant diﬀerence between target density after fermentation of FOS and after fermentation of the oligosaccharides: P < 0.05, #; P < 0.01, ##;
P < 0.001, ###.
Figure 5. MS/MS high-energy CID spectrum of a sodium adduct of ara5FA (fraction V, Figure 4), illustrating the fragmentation pattern and
nomenclature, and two diﬀerent proposed structures.
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to establish itself and induce disease.30 Over the past decade an
increase in cases of C. diﬃcile-associated diarrhea has been
observed. Only a limited number of antibiotics are available for
treatment of C. diﬃcile infections. Currently, vancomycin or
metronidazole is recommended for treatment, andmany patients
suﬀer from relapse following infections.31
Single-culture fermentations of C. diﬃcile showed that glucose
(positive control), starting material, and SAOS were able to
support bacterial growth, but FOS, LAOS, SFAOS, and LFAOS
did not sustain growth (Figure 7). Similar to what was seen in the
mixed fermentations, it was not possible to distinguish between the
eﬀects of the feruloylated and the nonferuloylated high molecular
weight fraction in the monoculture fermentations. It may be
speculated that the starting material and SAOS supported growth
of C. diﬃcile due to the high concentrations of monosaccharides
such as arabinose and glucose relative to oligosaccharides present
in these samples. It should be noted that single-culture studies do
not take substrate competition and possible positive or negative
eﬀects of secondary metabolites from competing microbiota into
account. The data obtained deserve further investigation in
mixed fecal fermentations. Nevertheless, the lack of induced
growth of C. diﬃcile provides a good indication that the tested
compounds will not stimulate this species in vivo. Both fecal
fermentations and single-culture experiments showed similar
results for both LAOS and LFAOS. Although the LFAOS tended
to elicit a higher selective stimulation of biﬁdobacteria than
LAOS, the results from these two fractions were not signiﬁcantly
diﬀerent. The eﬀects of these two highmolecular weight fractions
diﬀered signiﬁcantly from their low molecular weight counter-
parts. The membrane separation procedure applied in this
experimental setup provided a fast, but crude, method for an
initial separation based on size. As we reported recently,23 even a
single DP change in oligosaccharide chain length (of homo-
galacturonides) may elicit a diﬀerential response in fecal fermen-
tations. The data therefore provide an incentive to evaluate the
eﬀects of even more deﬁned structures with respect to the role of
feruloyl substitution and chain length for prebiotic response. The
HILIC separation procedure showed great potential in separat-
ing the feruloylated arabino-oligosaccharides according to chain
length. Post treatment with feruloyl esterases could ﬁnally
generate similar structures (or oligosaccharide mixtures having
similarly narrow DP proﬁles) with and without feruloyl substitu-
tions. The availability of more well-deﬁned structures, or of
oligosaccharide mixtures having very narrow chain-length proﬁles
and substitutions, could make it possible to examine and develop
an improved understanding of the functionality and possible
bioactive role of feruloyl-substituted arabino-oligosaccharides
and potentially provide a new base for upgrading of sugar beet
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Abstract Potato pulp is a poorly utilized, high-volume co-
processing product resulting from industrial potato starch
manufacturing. Potato pulp mainly consists of the tuber
plant cell wall material and is particularly rich in pectin,
notably galactan branched rhamnogalacturonan I type
pectin which has previously been shown to exhibit
promising properties as dietary fiber. The objective of this
study was to solubilize dietary fibers from potato pulp by a
one-step minimal treatment procedure and evaluate the
prebiotic potential of the fibers. Statistically designed
experiments were conducted to investigate the influence
of enzyme type, dosage, substrate level, incubation time,
and temperature on the enzyme catalyzed solubilization to
define the optimal minimal enzyme treatment for maximal
fiber solubilization. The result was a method that within
1 min released 75% [weight/weight (w/w)] dry matter from
1% (w/w) potato pulp treated with 1.0% (w/w) [enzyme/
substrate (E/S)] pectin lyase from Aspergillus nidulans and
1.0% (w/w) E/S polygalacturonase from Aspergillus acu-
leatus at pH 6.0 and 60 °C. Molecular size fractionation of
the solubilized fibers revealed two major fractions: one
fraction rich in galacturonic acid of 10–100 kDa indicating
mainly homogalacturonan, and a fraction >100 kDa rich in
galactose, presumably mainly made up of β-1,4-galactan
chains of rhamnogalacturonan I. When fermented in vitro
by microbial communities derived from fecal samples from
three healthy human volunteers, both of the solubilized
fiber fractions were more bifidogenic than fructo-
oligosaccharides (FOS). Notably the fibers having molec-
ular masses of >100 kDa selectively increased the densities
of Bifidobacterium spp. and Lactobacillus spp. 2–3 times
more than FOS.
Keywords Potato pulp . Dietary fiber . Pectin lyase .
Polygalacturonase . Galactan . Bifidobacterium
Introduction
Potato pulp resulting as a co-processing product from
industrial potato starch production is made up of the cell
walls of the potato tuber and is mainly composed of pectin,
cellulose, hemicelluloses, in addition to containing residual
starch (Meyer et al. 2009). The monomeric composition of
destarched potato pulp indicates that the potato pulp cell
wall polysaccharides are mainly composed of galactose,
galacturonic acid, arabinose, and rhamnose indicating most
of the cell wall material is made up of homogalacturonan
and rhamnogalacturonan I with long galactan side chains
(Thomassen and Meyer 2010). The fermentability of
enzymatically solubilized fibers from potato pulp was
studied already in 1998 in a small intervention trial in
which seven healthy human volunteers consumed the
potato fiber in different ways (raw, baked, etc.; Olesen et
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al. 1998). Consumption of the enzymatically solubilized
potato fibers increased the end-expiratory H2 and
delayed the oro-cecal transit time and the study therefore
concluded that the soluble potato fibers were fermentable
dietary fibers (Olesen et al. 1998). When rats consumed
similar enzymatically solubilized fibers from potato pulp,
they exhibited a significantly lower weight gain than
control groups fed with cellulose fibers or insoluble potato
pulp fibers (Lærke et al. 2007). In these studies, the
solubilized potato fibers were mixtures of different
molecular structures having different molecular masses.
A first step in obtaining at least a provisional understand-
ing, and a direction for designing the enzymatic solubili-
zation to produce fibers exerting maximal biological
benefits, would be to map the possible relationship
between the solubilized polysaccharide structures and
their putative biological effects by assessing the influence
of the molecular size and composition on the growth of
human intestinal bacteria.
Pectin can be solubilized from plant material by
different enzymes which has been shown by, e.g., Ishii
(1981; 1982). Previously in our lab, multicomponent plant
cell wall degrading enzyme preparations were used to
solubilize pectinaceous fibers from potato pulp (Meyer et
al. 2009). However, the use of monocomponent enzymes
for solubilization entails the possibility of targeting the
enzymatic attack of the substrate, avoiding undesirable
enzyme catalyzed degradation of the released fibers, and
may furthermore provide knowledge about the accessibil-
ity of the pectin in the plant cell wall material. Based on
the available compositional data, the soluble potato fibers
may be hypothesized to be mainly made up of rhamnoga-
lacturonan I fragments having extensive galactan side
chains (Meyer et al. 2009). Pectin lyase, polygalactur-
onase, and presumably pectin methyl esterase would
therefore be relevant enzyme candidates for solubilization
of such dietary fibers from potato pulp. Hence, the
hypothesis behind this study was that it should be possible
to solubilize the potential galactan-rhamnogalacturonan I
dietary fiber fraction from potato pulp by use of a few
selected enzyme activities attacking the pectin homoga-
lacturonan backbone, and the objective of the work was to
test this hypothesis. The action of selected pectinolytic
enzymes on potato pulp was examined in statistically
designed experiments in which the separate and interactive
effects of different reaction factors were also evaluated in
order to design a minimal procedure by which the
maximal amount of fiber could be released. The solubi-
lized fibers were subsequently fractionated into two large
fractions according to molecular mass and the effect of the
potential dietary fibers on the composition of human
intestinal bacterial ecosystems was evaluated by small
scale in vitro fermentation.
Materials and methods
Chemicals
Pectin from citrus fruits, isopropanol, pullulan, polygalactur-
onic acid, D-galactose, L-arabinose, L-rhamnose monohydrate,
D-fucose, D-mannose, D-galacturonic acid monohydrate, and
vitamin K1 were purchased from Sigma-Aldrich (Steinhein,
Germany). Dextran was from Pharmacia (Uppsala, Sweden)
and D-xylose and D-glucose from Merck (Darmstadt,
Germany). Trifluoroacetic acid was from Riedel-deHaën
(Seelze, Germany), anoxic phosphate buffered saline (PBS)
was from Oxoid (Greve, Denmark), FOS (DP 2–8;
Orafti®P95) were obtained from Beneo-Orafti (Tienen,
Belgium), and Tween80 from VWR (Darmstadt, Germany).
All chemicals used were analytical grade.
Pulp and enzymes
Fresh potato pulp was supplied by Lyckeby Stärkelsen
(Kristianstad, Sweden). The potato pulp was stored at −21 °C
until use. The enzymes used are listed in Table 1. The pectin
lyase (PL1), the polygalacturonase (PG1), and the pectin
methyl esterase (PME), all from Aspergillus nidulans, were
produced in fermentations essentially as described by Stratton
et al. (1998). The Pichia pastoris clones transformed with the
pectin lyase gene AN2569.2, the polygalacturonase gene
AN4372.2, and the pectin methyl esterase gene AN3390.2
were obtained from the Fungal Genetic Stock Center as
described by Bauer et al. (2005). The pectin lyase (PL2) from
Aspergillus niger was supplied by Danisco (Brabrand,
Denmark), and the polygalacturonase (PG2) from A.
aculeatus and the Viscozyme® L preparation were from
Novozymes (Bagsværd, Denmark).
Protein concentration in enzyme solutions
Protein was determined by bicinchoninic acid protein assay
with bovine serum albumin as standard (Thermo Fisher
Scientific, Rockford, IL).
Reducing ends
The amount of reducing ends was determined by a
modified down-scaled method described by Lever (1972,
1977). In brief, 1 M bismuth, 1 M potassium sodium
tartrate, and 3 M sodium hydroxide were mixed with
0.5 M sodium hydroxide and 5% [weight/volume (w/v)] 4-
hydroxybenzoic acid hydrazide in 0.5 M hydrochloric acid
in the ratio 1:899:100. The reagent was mixed with a
sample and incubated at 70 °C for 10 min, cooled to room
temperature, and the absorbance was measured at 410 nm
in an Infinite200 microplate reader (Tecan, Salzburg,
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Austria). Data collection was controlled by the program
Tecan i-control version 1.5.14.0 (Tecan). Galacturonic
acid was applied as standard.
Acid hydrolysis and high-performance anion-exchange
chromatography
Hydrolysis of polysaccharides and separation and quantifi-
cation of the monosaccharides by high-performance anion-
exchange chromatography were done as described by
Thomassen and Meyer (2010).
Protein determination in fiber
The protein content was determined as total amino acid
assessment after 6 M hydrochloric acid hydrolysis followed
by separation by ion exchange chromatography (Barkholt
and Jensen 1989).
High-performance size-exclusion chromatography
High-performance size-exclusion chromatography was per-
formed as described by Rasmussen and Meyer (2010) with
the following modifications: The mobile phase and the
sample solution matrix were 0.1 M acetate buffer pH 6.0.
The injected volume was 25 μl and the analysis was carried
out at 30 °C. Molecular markers were pullulan standards with
a mass of 1.3, 10, and 400 kDa, respectively, and dextran with
a mass of 110 kDa.
Enzyme activities
Pectin lyase activity was measured on 1 g/l pectin from citrus
fruits by incubating 1% (w/w) E/S inMcilvaine buffer (mixture
of 0.1M citric acid and 0.2Mdisodium hydrogen phosphate) at
pH 6.0 and 60 °C. The increase in absorbance was determined
at 235 nm during 4 min in an Infinite200 microplate reader
(Tecan, Salzburg, Austria); the data collection was controlled
by the program Tecan i-control version 1.5.14.0 (Tecan). The
extinction coefficient used was 5.5 mM−1·1 -1 (Van den
Broek et al. 1997). The polygalacturonase activity was
measured on 2 g/l polygalacturonic acid by incubating
0.01–0.5% (w/w) E/S in Mcilvaine buffer at pH 6.0 and
60 °C. Samples were collected every minute for 5 min. The
enzyme was inactivated by adding 50 mM NaOH and the
amount of reducing ends was measured as described above.
Removal of starch from potato pulp
The starch was removed from the potato pulp using the
rationalized one-step method described by Thomassen and
Meyer (2010).
Release of fiber from potato pulp
Definition of the required enzyme activities
The statistically designed experiments were randomized,
quadratic modified simplex centroid designs. The tree factors
were: PL1 dose, PG1 dose, PME dose [each 0–5% (w/w) E/S]
in all runs. 1% (w/w) destarched potato pulp in 0.1 M
phosphate buffer pH 6.0 was preheated to 40 °C for 5 min and
the enzymes added. The samples were incubated in a heating
shaker (Eppendorf, Hauppauge, NY) at 750 rpm for 15 min at
40 °C followed by incubation at 100 °C for 10 min before
centrifugation (15,000×g for 10 min). The supernatant was
filtered using a 0.2 μm syringe tip filter (Phenomenex,
Torrance, CA) and precipitated with 70% isopropanol for
30 min at room temperature. After centrifugation (5,000×g
for 5 min) remaining liquid was removed by incubation over
night at 105 °C and the dry matter determined.
Definition of the optimal experimental conditions
The experiments were randomized, quadratic central
composite designs. Each design contained 26 different
combinations of the five factors: dry matter [1–6% (w/w)],
temperature (40–60 °C), time (1–15 min), PL1 dose [0.2–





Activity at pH 6,
60 °C (U/mg protein)
Family EC no. Reference
Pectin lyase (PL1) A. nidulans 40 27.5±0.6 0.8± 0.1 PL1 4.2.2.10 Bauer et al. (2006)
Pectin lyase (PL2) A. niger 38 17.2±1.4 0.2±0.0 PL1 4.2.2.10 Limberg et al. (2000)
Polygalacturonase (PG1) A. nidulans 38 56.4±1.7 107±15 GH28 3.2.1.15 Bauer et al. (2006)
Polygalacturonase (PG2)a A. aculeatus 39 – 11±0.8 GH28 3.2.1.15 –
Pectin methyl esterase (PME) A. nidulans 36 55.5±1.3 n.d. CE8 3.1.1.11 Bauer et al. (2006)
The protein levels were used to dose the enzymes at equivalent protein/substrate (w/w) ratios in the fiber release experiments
n.d. Not determined
a Solid enzyme preparation
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2.5% (w/w) E/S], and PG1 dose [0.2–2.5% (w/w) E/S] with
three center points. Destarched potato pulp [1% (w/w)] in
0.1 M phosphate buffer pH 6.0 was preheated to 40–60 °C for
5 min, and the enzymes were added. The samples were
incubated in a heating shaker at 750 rpm for 1–15 min at 40–
60 °C then at 100 °C for 10 min before centrifugation
(15,000×g for 10 min). The supernatant was then filtered
and the solubilized polysaccharides precipitated in isopropa-
nol as described above.
Definition of the right enzyme combination and dose
Destarched potato pulp [1% (w/w)] was preheated at 60 °C
in 0.1 M phosphate buffer pH 6.0 for 5 min. PL1, PL2,
PG1, and PG2 [0–2.5% (w/w)] were added in different
combinations, and the samples were incubated in a heating
shaker at 750 rpm at 60 °C for 0–1 min and at 100 °C for
10 min followed by centrifugation, filtration, and precipi-
tation as described above.
Minimal procedure on destarched or crude potato pulp
Destarched potato pulp [1% (w/w)] or crude potato pulp
corresponding to 1% (w/w) destarched potato pulp was
preheated at 60 °C in 0.1 M phosphate buffer pH 6.0 for
5 min. PL1 [1.0% (w/w) E/S] and PG2 [1.0% (w/w) E/S]
were added and the samples were incubated at 750 rpm at
60 °C for 1, 15, 30, or 60 min and 100 °C for 10 min
followed by centrifugation, filtration, and precipitation as
described above. Samples where no enzyme was added
were treated by incubating the samples at 60 °C for 1 min.
Solubilization of dry matter by Viscozyme® L
Destarched potato pulp [1% (w/w)] or crude potato pulp
corresponding to 1% (w/w) destarched potato pulp was treated
by the optimized procedure described by Meyer et al. (2009).
Fiber production and fractionation: 3 L process
Crude potato pulp was preheated at 60 °C in 0.1 M
phosphate buffer pH 6.0 for 5 min. PL1 [1% (w/w) E/S]
and PG2 [1% (w/w) E/S] was added and incubated at 60 °C
for 1 min followed by heat treatment at 100 °C for 10 min.
The supernatant was filtered through Celite® 545 followed
by ultrafiltration. First, the supernatant was filtered using a
100 kDa polyethersulfone spiral wound ultrafiltration
module (Millipore, Ballerica, MA). Then the permeate
was filtered through a 10 kDa polyethersulfone spiral
wound ultrafiltration module (Millipore). The ultrafiltration
lead to three fractions: <10, 10–100, and <100 kDa. The
fractions were concentrated and precipitated by isopropa-
nol. The precipitated material was collected after centrifu-
gation (2,000×g, 15 min) and dried over night at 40 °C.
The fractions were ground to <2 mm in an Ultra Centrifugal
Mill ZM 200 (Retsch, Haan, Germany). The protein
content, monosaccharide composition, and size distribution
were analyzed as described above.
Analysis of biological activity
Subjects and fecal sampling
Fecal samples were obtained from three healthy volunteers
(mean age 42.7±10.0 years). None of the participants had
been treated with antibiotics for at least 3 months before
attendance and had no history of gastrointestinal disorder.
Whole stools were collected in airtight containers, imme-
diately stored at 4 °C, and processed within 12 h. The fresh
feces samples were homogenized in 50% glycerol (1:1
dilution) in an anerobic cabinet (containing 10% H2, 10%
CO2, and 80% N2) and stored at −80 °C until further
analysis as described below.
In vitro fermentation
Fibers or FOS were added to an autoclaved minimal
basal medium to a final concentration of 5 g (dry
matter)/l in a reaction volume of 2 ml. FOS was applied
as a standard with known bifidogenic effect. The minimal
basal medium contained 2 g/l peptone water, 1 g/l yeast
extract, 0.1 g/l NaCl (1.71 mM), 0.04 g/l (0.23 mM) K2HPO4,
0.04 g/l (0.29 mM) KH2PO4, 0.01 g/l (0.04 mM)
MgSO4∙7H2O, 0.01 g/l (0.07 mM) CaCl2∙2H2O,
2 g/l (23.81 mM) NaHCO3, 0.5 g/l bile salts, 0.5 g/l
L-cysteine hydrochloride, 0.005 g/l hemin, 10 μl/l vitamin
K1 (0.02 mM), 2 ml/l Tween 80, and 0.05‰ (w/v) resazurin
solution. A 10% (w/v) fecal slurry was prepared by mixing
the feces stored in 50% glycerol with anoxic PBS. The
fiber samples were sterilized by ultraviolet light for
3 min and reduced for 24 h in an anerobic cabinet. After
the reduction, the samples were checked to ensure that
no contamination was present. The reduced minimal
medium with added fibers was inoculated to a final
concentration of 1% (w/v) feces. Fermentations of each
fecal sample of each healthy volunteer was done in
triplicate to give 3×3 fermentations that were incubated
at 37 °C for 24 h in an anerobic cabinet.
Extraction of bacterial DNA from fermentation samples
Deoxyribonucleic acid (DNA) was extracted from fermen-
tation samples using the QIAamp DNA Stool mini kit
(Qiagen, Hilden, Germany) with a bead beater step in
advance, as previously described (Leser et al. 2000). The
purified DNA was stored at −20 °C until use.
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Real-time PCR assay conditions
Amplification and detection of purified bacterial DNA by
real-time polymerase chain reaction (PCR) was performed
with the ABI-Prism 7900 HT (Applied Biosystems,
Carlsbad, CA) using optical grade 384-well plates. Each
amplification reaction was done in duplicate in a final
volume of 20 μl containing; 10 μl EXPRESS SYBR®
GreenER™ qPCR SuperMix (Invitrogen, Taastrup, Den-
mark), 10 pmol of each of the primers (Eurofins MWG
Synthesis, Ebersberg, Germany), 2 μl template DNA, and
nuclease-free water purified for PCR. The amplification
program consisted of 1 cycle at 50 °C for 2 min; 1 cycle at
95 °C for 10 min; 40 cycles at 95 °C for 15 s, 60 °C for
1 min; and finally 1 cycle of melting curve analysis for
amplicon specificity at 95 °C for 15 s, 60 °C for 20 s,
increasing ramp rate by 2% until 95 °C for 15 s. The 16 S
rRNA primers used are listed in Table 2. Standard curves
were created for each primer set using serial tenfold
dilutions of bacterial DNA extracted from one of the
fermentation samples with the threshold cycle (Ct) values
calculated by the ABI software (SDS 2.2). The analysis of
the standard curves allowed verification of PCR efficiency
for the chosen PCR conditions (Table 2). The DNA level of
the bacterial target groups for each reaction was calculated
from the standard curves. All results were calculated
relatively as ratios of species DNA levels to total bacteria
expression levels in order to correct data for differences in
total DNA concentration between individual samples.
Statistics
Calculation of means and standard deviations were done in
Excel (Microsoft). The program used for design of the
experimental templates and the evaluation of the effects and
the interactions by multiple linear regression was MODDE
version 7.0.0.1 (Umetrics, Umeå, Sweden). Statistical
analysis of the bioactivity data was performed using
GraphPad PRISM v5.03 for Windows. One-way analysis
of variance (ANOVA) and Dunnett’s posthoc test were
used to determine significant differences among bacteria
populations using the different applied fibers compared
to FOS. Differences were considered to be significant
when P<0.05. All reported data are given as average
values determined after minimum duplicate determination.
Results
Enzyme concentration and activity
The activities of the pectin lyases ranged from 0.2 to 0.8 U/mg,
and the activity of the two polygalacturonases were 11 and 107
U/mg, respectively, lowest for PG2, the enzyme from A.
aculeatus (Table 1).
Release of fibers from potato pulp
Enzyme activities needed
The response contour plot prepared from the data
indicated that it was possible to release at least 70% of
the dry matter by employing only PL1 and PG1 (Fig. 1).
Furthermore, the data indicated that some dry matter was
released from the pulp even without addition of PL1, PG1
or PME (Fig. 1).
Optimal experimental conditions
Since PME was not needed to release >70% of the dry
matter from destarched potato pulp, only the temperature,
dry matter, incubation time, and enzyme dose of PL1 and
PG1 were varied. It was possible to release 74–75% of the
dry matter using 1% (w/w) potato pulp, and 2.5% (w/w)
E/S of both enzymes at 40 °C for 15 min or at 60 °C for
1 min (data not shown). The response surface plot also
indicated that 70% (w/w) of the dry matter could be
released from destarched potato pulp by enzymatic treat-
Table 2 16S rRNA primers for real-time PCR used to quantify the level of the four different bacterial taxa in the in vitro fermentations of the
fecal samples with different potato fibers




Product size (bp) Correlation
coefficient (R2)
Efficiency (%) Reference
Bifidobacterium spp. cgc gtc ygg tgt gaa ag ccc cac atc cag cat cca 244 0.991 94 Delroisse et al. (2008)
Lactobacillus spp. agc agt agg gaa tct tcc a cac cgc tac aca tgg ag 341 0.992 102 Heilig et al. (2002),
Walter et al. (2000)
Firmicutes phylum gga gya tgt ggt tta att cga agc a agc tga cga caa cca tgc ac 126 0.999 100 Guo et al. (2008)
Bacteroidetes phylum gga rca tgt ggt tta att cga tga t agc tga cga caa cca tgc ag 126 0.999 97 Guo et al. (2008)
Total bacteriaa cgg caa cga gcg caa ccc cca ttg tag cac gtg tgt agc c 130 0.999 97 Denman and
McSweeney (2006)
a PCR for the total bacteria primer set was run in parallel for each set of primers for all samples
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ment for 1 min at 60 °C, 1% (w/w) dry matter using either
of three different treatments: 2.5% (w/w) E/S PL1 and 0.2%
(w/w) E/S PG1, or 0.7% (w/w) E/S PL1 and 2.5% (w/w)
E/S PG1, or 1.5% (w/w) E/S of both enzymes (Fig. 2). The
initial dry matter level had a significant effect on the
amount of released dry matter (Fig. 3). The response
surface plots indicated that to have a yield of at least 70%,
the amount of dry matter should be maximum 1.3% (w/w).
Multiple linear regression analysis of the data showed that
an increase in PL1 and PG1 dose would significantly
increase the amount of released dry matter whereas a
decrease in dry matter also increased the release of dry
matter (Table 3). In addition, pectin lyase and dry matter
interaction had a significant effect on the amount of
released dry matter.
Enzyme combination and dose
To assess the optimal procedure for release of minimum
70% (w/w) dry matter from destarched potato pulp,
experiments were made using PL1, PL2, PG1, and PG2 in
different doses and combinations under the conditions
found above. Of the dry matter, 15% (w/w) was released
during the 5 min of preheating with no enzyme present and
around 41% (w/w) after additional 1 min of heating
(Fig. 4a). Incubation with 0.8 and/or 1.6% (w/w) E/S
PL1, PL2, PG1, or PG2 released 41–68% (w/w) dry matter
(Fig. 4a).
The yield increased in response to PL1 and PG1 dosage;
dry matter yield started from 59%, when 0.2% (w/w) E/S
PL1 and PG1 was added and seemed to reach a maximum
at 74–75% (w/w) dry matter, when 1.0% or 2.5% (w/w) of
each enzyme were added (Fig. 4a).
Treatments with a combination of 0.2–0.8% (w/w) E/S
PL1 and PG2 released 60–70% (w/w) of the dry matter,
whereas 1.0–2.5% (w/w) E/S of PL1 and PG2 released 73–
76% of the dry matter (Fig. 4b).
Similar experiments were made with PL2+PG1 and
PL2+PG2, but the general yields obtained were lower
than those obtained with PL1+PG1 and PL1+PG2 (data
not shown).
Based on the results presented above, the best minimal
procedure for releasing 75% of the dry matter was: 1.0%
(w/w) E/S PL1 and 1.0% (w/w) E/S PG2 incubated with
1% (w/w) destarched potato pulp for 1 min at pH 6, 60 °C.
If the objective was to use only one enzyme, it was possible
to release 68% dry matter by applying 0.8% (w/w) E/S PG2
(Fig. 4a). The minimal enzyme dose for releasing 70% by
weight of dry matter was 0.8% (w/w) E/S PL1 and 0.8%
(w/w) E/S PG2 (Fig. 4b). It may be possible to use lower
enzyme dosage, but most likely, it requires the incubation
time to be extended.
Fractionation of released fibers
The minimal procedure using PL1+PG2 was scaled up and
the released fibers were fractionated into three fractions: >10,
10–100, and >100 kDa. The distribution of the dry matter in
fraction 10–100 and >100 kDa was 17% and 71%, respec-
tively. The fraction containing molecules with a mass<
10 kDa was not possible to precipitate with isopropanol and
was therefore considered to be the mass not present in the two
other fractions (11%).
Fig. 2 A three-dimensional response surface showing the amount of
released dry matter [% (w/w)] as function of PL1 [% (w/w) E/S] and
PG1 [% (w/w) E/S]. Q2=0.883, R2=0.991; constant factor: tempera-
ture=60 °C, incubation time=1 min, dry matter=1% w/w
Fig. 1 A response contour plot showing the amount of released dry
matter from potato pulp using PL1, PG1, and PME at pH 6, 40 °C.
PL1=1.00 means that PL1 was present in the highest dose [5% (w/w)
E/S] and no other enzymes were added, and PL1=0.00 means that
PL1 was not present and that the full dose of enzyme was split equally
between PME [2.5% (w/w) E/S] and PG1 [2.5% (w/w) E/S], etc
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Fiber from destarched versus from crude potato pulp
Extended treatment of crude and destarched potato pulp for
up to 1 h under minimal conditions neither increase nor
decrease the yield of released fibers; neither did the yield of
dry matter released during extended treatment without
addition of enzyme change (data not shown). Incubation
of crude and destarched potato pulp with Viscozyme® L (as
described by Meyer et al. 2009) released significantly less
dry matter than incubation with the optimal procedure (data
not shown).
Characterization of the released fibers
Monosaccharide composition of released fibers
The monosaccharide composition in the samples DNE,
CNE, DPP, CPP, and CPP>100 (Table 4) were generally
similar, containing approximately 55–66% galactose, 9–
10% arabinose, and 1.3–1.7% rhamnose, but with some
variation in the glucose levels (Table 5). In contrast, the
main component in CPP10–100 was galacturonic acid
(47.7±5.6%), but the rhamnose level was approximately
the same as in the other fibers (1.4±0.1%; Table 5). No
fucose or xylose was detected in any of the fiber samples.
Molecular size of released fibers
Size exclusion chromatograms of the DNE showed that the
majority of the released dry matter had a molecular mass of
approximately 0.4 and 1.0 kDa (Fig. 5). A limited part of
the sample was made up of molecules having a higher
molecular mass. A similar chromatogram was obtained for
CNE (data not shown). The chromatogram for CPP
contained four main peaks: 0.4, 1.0, 4.8, and >400 kDa.
A similar chromatogram was obtained for DPP (data not
shown). The molecular mass of CPP10–100 was 5.4 kDa
at the highest point of molecular mass distributed almost
equally on each side of the chromatogram top point.
Furthermore, there was a minor peak at molecular mass
of around 0.4 kDa (Fig. 5). In CPP>100, the majority of
the dry matter had molecular mass>110 kDa with
maximum >400 kDa (Fig. 5).
Fig. 3 Three-dimensional response surface showing the amount of
released dry matter [yield,% (w/w)] as function of a PL1 [% (w/w)
E/S] and initial dry matter [% (w/w)] and b PG1 [% (w/w) E/S] and
initial dry matter [% (w/w)]. Q2=0.883, R2=0.991. The constant
factors are set to the center values
Table 3 Multiple linear regression results on the released dry matter
obtained after optimization of experimental conditions for fiber release
(Q2=0.883, R2=0.991)
Parameters and interactions (×) Percent by weight of dry matter
Coefficient P*
Temperature −0.13 No effect
PL1 2.05 1.05×10−5
PG1 2.41 1.07×10−6
Dry matter −17.46 7.80×10−24
Time 0.71 No effect
PL1×dry matter −0.92 0.006
Constant 47.66 1.47×10−33
P* =0.05 indicates significance at the 95% level. The validity of the model
was confirmed by the value of the center points [47.71±1.25% (w/w)]
being close to the coefficient of the constant
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Biological activity
After fermentation in fecal slurries obtained from three
different subjects, quantitative real-time PCR was applied
to measure the density of gene targets encoding 16 S
rRNA of selected bacterial taxonomic units (Fig. 6). The
ability of the released fibers (Table 4) to selectively
stimulate the growth of the given bacterial taxa was
compared to that of FOS. The fecal communities
fermented on CPP>100 had a significantly higher content
of Bifidobacterium than the same fecal communities
fermented on FOS (P<0.05; Fig. 6a). A similar trend
was found for the samples fermented on CPP10–100, but
the difference to FOS did not reach statistical significance
(P<0.10). The Bacteroidetes 16 S rRNA gene content was
significantly higher in the fecal communities fermented on
CNE than those fermented on FOS (P<0.05; Fig. 6c).
There were no differences in the Lactobacillus and
Firmicutes content between the fermentation samples
containing the applied fibers and FOS (Fig. 6b, d,
respectively).
Discussion
When evaluated in a tertiary mixture design using PME,
PL1 and PG1, it was possible to release >70% of the dry
matter from destarched potato pulp by a combination of
PL1 and PG1; the combination released more dry matter
than either enzyme separately (Fig. 1). This confirmed that
homogalacturonan contained galacturonic acid units both
with and without methyl group substitutions and that bonds
between both substituted and unsubstituted galacturonic
acid moieties should be hydrolyzed in order to release the
fibers. PME was expected to catalyze the removal of the
methyl groups, reducing the need for the pectin lyase.
However, the direct effect of PL treatment was higher in
this experimental setup.
Optimization of fiber release
The incubation time and temperature did not significantly
change the amount of dry matter released and therefore



















































0.2 % w/w PL, 0.2 % w/w PG
0.4 % w/w PL, 0.4 % w/w PG
0.8 % w/w PL, 0.8 % w/w PG
1.0 % w/w PL, 1.0 % w/w PG
2.5 % w/w PL, 2.5 % w/w PG
a b
Fig. 4 Released dry matter
from destarched potato pulp at
pH 6.0 and 60 °C by applying
a no enzyme or one enzyme
or b different combinations of
different enzymes
Table 4 The abbreviated name codes of the released fibers
Sample Abbreviated name code
DNE Destarched potato pulp, fiber released by addition of No Enzyme
DPP Destarched potato pulp, fiber released by Pectin lyase and Polygalacturonase
CNE Crude potato pulp, fiber released by addition of No Enzyme
CPP Crude potato pulp, fiber released by Pectin lyase and Polygalacturonase
CPP10–100 Crude potato pulp, fiber released by Pectin lyase and Polygalacturonase, fraction 10–100kDa
CPP>100 Crude potato pulp, fiber released by Pectin lyase and Polygalacturonase, fraction >100kDa
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higher temperature was chosen to minimize the risk of
microbial growth. Approximately 21–22% by weight of
the crude (dry) potato pulp is starch (Thomassen and
Meyer 2010). The optimization experiments were carried
out on destarched potato pulp to avoid interference from
starch on the enzymatic release and the in vitro fermen-
tation. The same amount of dry matter was released from
destarched and crude potato pulp by applying the minimal
procedure, indicating that the remaining starch polymers
in crude potato pulp were insoluble.
Release of fiber from potato pulp by Viscozyme® L
It has been shown that it is possible to release 28% by
weight of dry matter from destarched potato pulp by and
optimized Viscozyme® L treatment (Meyer et al. 2009).
The experiment was repeated during this study, but the
amount of released dry matter was insignificant as
compared to the amount released by the minimal procedure.
The difference might be due to the Viscozyme® preparation
comprising a number of pectinolytic activities vatalyzing
the degradation of the fibers to a low molecular size, not able
to be precipitated by isopropanol and thereby determined by
the present method.
Release of fibers from potato pulp without addition of enzyme
When destarched potato pulp was incubated at pH 6 and 60 °C
for 1 min 41% by weight of the dry matter was released
(Fig. 4b). A similar amount of dry matter was released from
crude potato pulp (data not shown) eliminating the possibility
that the enzyme used for starch removal caused the increased
amount of released dry matter. The possible influence of
divalent cations viz. chelation might play a role, but this
hypothesis requires further experimental substantiation.
Characterization of the released fibers
The monosaccharide compositions indicated that CPP10–100
and CPP>100 were mainly made up of homogalacturonan
and rhamnogalacturonan I polysaccharides, respectively. The
monosaccharide composition and size-exclusion chromato-
gram indicated that CPP>100 mainly consisted of polysac-
charides of homogalacturonan and rhamnogalacturonan I with
large galactan side chains. This is in complete accordance
with the data obtained with Viscozyme® L treatment on
destarched potato pulp (Meyer et al. 2009) and the tentative
conclusion that the enzymatically released high molecular
weight fraction contained relatively large galactan side
chains (Meyer et al. 2009).
Biological activity
The bioactivity of the released fibers (Table 5) was tested
by fermentation in fecal bacterial communities obtained
from three healthy human subjects. The effect of the fibers
on the content of Bifidobacterium and Lactobacillus was
compared to the effect of FOS. FOS was used as a standard
Fig. 5 Size exclusion
chromatogram of the fractions
released from potato pulp
% (mole) DNE DPP CNE CPP CPP10–100 CPP>100
Glucose 18.1±0.4 10.0±0.5 11.7±0.7 4.8±0.1 10.1±0.5 7.1±1.0
Rhamnose 1.4±0.1 1.3±0.1 1.5±0.1 1.3±0.1 1.4±0.1 1.7±0.3
Galacturonic acid 16.7±0.4 18.5±2.4 14.7±2.8 22.7±1.3 47.7±5.6 13.6±5.0
Galactose 54.8±2.7 58.3±1.2 62.7±3.4 59.1±0.3 32.4±0.4 65.5±0.7
Arabinose 9.0±1.9 9.6±1.2 9.5±1.3 8.6±1.2 3.7±0.7 8.5±0.8
Mannose 0.0±0.0 0.0±0.0 0.0±0.0 1.1±0.1 3.3±0.2 2.3±0.3
Protein n.d. 2.3 n.d. 1.7 1.5 1.4
Table 5 Carbohydrate and pro-
tein content in the fiber released
from potato pulp by the minimal
procedure: 1% (w/w) potato
pulp treated with 1.0% (w/w) E/
S PL1 and 1% (w/w) E/S PG2 at
pH 6.0 and 60 °C for 1 min
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based on its known selective effect on the content of
Bifidobacterium and Lactobacillus (Palframan et al. 2002;
Rycroft et al. 2001; Sanz et al. 2005). Bifidobacterium and
Lactobacillus (in adults consisting of about 4% and less
than 2% of the total microbiota, respectively) were
included in the analysis, since they are associated with
various health benefits in the colon and hence target for
prebiotic treatment (Kleerebezem and Vaughan 2009).
The Bacteroidetes and Firmicutes phyla were included in the
qPCR analysis to study changes in the overall composition
of the intestinal microbiota, which in humans is dominated
by these two phyla. The balance between them is believed to
play a role, e.g., in development of obesity and intestinal
inflammation (Guo et al. 2008; Sokol et al. 2009; Turnbaugh
et al. 2006).
The density of Bifidobacterium was higher after
fermentation on four out of six applied fibers compared
to FOS (Fig. 6a). The stimulation of Bifidobacterial growth
by CPP>100 was significantly higher than FOS (P<0.05),
and a similar trend was observed for CPP10–100. Addition-
ally, CPP10–100 and CPP>100 also stimulated the growth
of Lactobacillus equally well as FOS. These results indicate
that CPP10–100 and CPP>100 have beneficial effects on the
fecal microbiota composition. When considering the differ-
ences in the monosaccharide compositions of the CPP10–
100 and CPP>100 fibers, described above, the data also
indicate that especially long galactan side chains and
presumably also homogalacturonan could be the reason for
the selective stimulation of the growth of Bifidobacterium
and Lactobacillus. Van Laere et al. (2000) tested the
fermentability of arabinogalactan-enriched polysaccharides
from soy on pure cultures of Bifidobacterium and Lactoba-
cillus and showed that both Bifidobacterium and Lactoba-
cillus species were able to partly degrade these fibers. The
level of Bacteroidetes was significantly higher in the
microbial communities fermented on CNE than on FOS.
DNE and CNE have similar monosaccharide composition as
some of the other fibers but lower average molecular mass
(mainly <1 kDa). Van Laere et al. (2000) showed that
Bacteroides strains (belonging to the Bacteroidetes phylum)
were able to degrade arabinogalactooligosaccharides which
could cause the effect shown in Fig. 6c, where CNE
containing mainly oligosaccharides have predominant ability
to selectively increase the abundancy of the Bacteroidetes. It
should be noted that the amount of dry matter added in the in
vitro fermentation was the same for all fibers and since the
amount of dry matter released without addition of enzymes
was less than when enzymes were added, the relative amount
of added starch/glucose in fermentation with CNE and DNE
was higher. Pure culture experiments have been conducted in
previews studies to reveal differences in the growth and
degradation kinetics of specific bacteria (Olano-Martin et al.
Fig. 6 The biological activity of
the fibers on a Bifidobacterium,
b Lactobacillus, c Bacteroidetes,
and d Firmicutes. The bars
represent the average±SEM of
triplicate fermentations. DNA
amount in the fermentation
samples of FOS was set to
100%. Asterisks indicate a
significant difference from the
fermentation samples containing
FOS; *P<0.05
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2002; Rossi et al. 2005). However, the use of human feces as
inocula, as done in this study, gives the ability to examine
simultaneous effects on growth of more bacterial groups at
the same time and to address selective stimulation of given
bacterial taxa in the complex ecosystem constituted by the
fecal population. However, one cannot draw conclusions
from in vitro fermentation on the efficiency of the prebiotic
capacity of the fiber fractions but the prebiotic (bifidogenic)
effect must be considered as promising with regard to
enzymatic released potato fiber as a prebiotic candidate.
In potato pulp galactan, the galactose units are expected
to be mainly β-1,4-linked. By use of the CAZY database
(Cantarel et al. 2009) different species within Bifidobacte-
rium, Bacteroidetes, and Firmicutes were all found to
contain both β-galactosidase (EC 3.2.1.23), endo-β-1,6-
galactanase (EC 3.2.1.-), β-1,3-galactosidase (EC 3.2.1.145),
and endo-β-1,4-galactanase (EC 3.2.1.89). Lactobacillus
species contain the same enzyme activities except endo-
β-1,6-galactanase (EC 3.2.1.-). The response in Fig. 6a for
CPP>100 might indicate that bifidobacteria express partic-
ularly high levels of β-galactanase activity that catalyze the
degradation of β-1,4-galactan allowing the bacteria to utilize
the β-1,4-galactan as a carbon source. Further research is,
however, required to confirm this. In any case, the results
obtained in this study indicate that the enzymatically
produced β-1,4-galactan rich potato fibers, especially those
with high molecular weights, may have potential as
functional food ingredients with bifidogenic properties.
Acknowledgments We thank the employees at Gums and Systems
Development, Danisco (Brabrand, Denmark) for the help and
supervision during upscaling the dietary fiber release procedure. The
authors would like to acknowledge Fungal Genetic Stock Center for
the Pichia pastoris clone expressing the pectin lyase gene AN2569.2,
the polygalacturonase gene AN4372.2, and the pectin methyl esterase
gene AN3390.2 and Lyckeby Stärkelsen (Kristianstad, Sweden) for
supplying the potato pulp. This study was supported by the Danish
Strategic Research Council’s Committee on Food and Health (FøSu,
Center for Biological Production of Dietary Fibres and Prebiotics, no.
2101-06-0067). Financial support from the FOOD Denmark Graduate
School, Center for Advanced Food Studies, Denmark, is also
acknowledged.
References
Barkholt V, Jensen AL (1989) Amino-acid analysis—determination of
cysteine plus half-cystine in proteins after hydrochloric-acid
hydrolysis with a disulfide compound as additive. Anal Biochem
177:318–322
Bauer S, Vasu P, Mort AJ, Somerville CR (2005) Cloning, expression,
and characterization of an oligo-xyloglucan reducing end-specific
xyloglucanobiohydrolase from Aspergillus nidulans. Carbohydr
Res 340:2590–2597
Bauer S, Vasu P, Persson S, Mort AJ, Somerville CR (2006)
Development and application of a suite of polysaccharide-
degrading enzymes for analyzing plant cell walls. Proc Natl Acad
Sci USA 103:11417–11422
Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V,
Henrissat B (2009) The carbohydrate-active enzymes database
(CAZy): an expert resource for glycogenomics. Nucleic Acids
Res 37:D233–D238. http://www.cazy.org/b.html. Accessed 27
September 2010
Delroisse JM, Boulvin AL, Parmentier I, Dauphin RD, Vandenbol M,
Portetelle D (2008) Quantification of Bifidobacterium spp. and
Lactobacillus spp. in rat fecal samples by real-time PCR.
Microbiol Res 163:663–670
Denman SE, McSweeney CS (2006) Development of a real-time
PCR assay for monitoring anaerobic fungal and cellulolytic
bacterial populations within the rumen. FEMS Microbiol Ecol
58:572–582
Guo X, Xia X, Tang R, Zhou J, Zhao H, Wang K (2008) Development
of a real-time PCR method for Firmicutes and Bacteroidetes in
faeces and its application to quantify intestinal population of
obese and lean pigs. Lett Appl Microbiol 47:367–373
Heilig HGHJ, Zoetendal EG, Vaughan EE, Marteau P, Akkermans
ADL, de Vos WM (2002) Molecular diversity of Lactobacillus
spp. and other lactic acid bacteria in the human intestine as
determined by specific amplification of 16 S ribosomal DNA.
Appl Environ Microbiol 68:114–123
Ishii S (1981) Isolation and characterization of cell-wall pectic
substances from potato-tuber. Phytochemistry 20:2329–2333
Ishii S (1982) Enzymatic extraction and linkage analysis of pectic
polysaccharides from onion. Phytochemistry 21:778–780
Kleerebezem M, Vaughan EE (2009) Probiotic and gut Lactobacilli
and Bifidobacteria: molecular approaches to study diversity and
activity. Annu Rev Microbiol 63:269–290
Lærke HN, Meyer AS, Kaack KV, Larsen T (2007) Soluble fiber
extracted from potato pulp is highly fermentable but has no effect
on risk markers of diabetes and cardiovascular disease in Goto-
Kakizaki rats. Nutr Res 27:152–160
Leser TD, Lindecrona RH, Jensen TK, Jensen BB, Moller K (2000)
Changes in bacterial community structure in the colon of pigs fed
different experimental diets and after infection with Brachyspira
hyodysenteriae. Appl Environ Microbiol 66:3290–3296
Lever M (1972) New reaction for colorimetric determination of
carbohydrates. Anal Biochem 47:273–279
Lever M (1977) Carbohydrate determination with 4-hydroxybenzoic
acid hydrazide (Pahbah)—effect of bismuth on reaction. Anal
Biochem 81:21–27
Limberg G, Korner R, Buchholt HC, Christensen TMIE, Roepstorff P,
Mikkelsen JD (2000) Analysis of pectin structure part 1—
analysis of different de-esterification mechanisms for pectin by
enzymatic fingerprinting using endopectin lyase and endopoly-
galacturonase II from A. niger. Carbohydr Res 327:293–307
Meyer AS, Dam BR, Laerke HN (2009) Enzymatic solubilization of a
pectinaceous dietary fiber fraction from potato pulp: optimization
of the fiber extraction process. Biochem Eng J 43:106–112
Olano-Martin E, Gibson GR, Rastall RA (2002) Comparison of the in
vitro bifidogenic properties of pectins and pectic-oligosaccharides. J
Appl Microbiol 93:505–511
Olesen M, Gudmand-Hoyer E, Norsker M, Kofod L, Adler-Nissen J
(1998) Fermentability of an enzymatically modified solubilised
potato polysaccharide (SPP). Eur J Clin Nutr 52:110–114
Palframan RJ, Gibson GR, Rastall RA (2002) Effect of pH and dose
on the growth of gut bacteria on prebiotic carbohydrates in vitro.
Anaerobe 8:287–292
Rasmussen LE, Meyer AS (2010) Size exclusion chromatography for
the quantitative profiling of the enzyme-catalyzed hydrolysis of
xylo-oligosaccharides. J Agric Food Chem 58:762–769
Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S,
Matteuzzi D (2005) Fermentation of fructooligosaccharides and
inulin by bifidobacteria: a comparative study of pure and fecal
cultures. Appl Environ Microbiol 71:6150–6158
Appl Microbiol Biotechnol (2011) 90:873–884 883
Rycroft CE, Jones MR, Gibson GR, Rastall RA (2001) A comparative
in vitro evaluation of the fermentation properties of prebiotic
oligosaccharides. J Appl Microbiol 91:878–887
Sanz ML, Gibson GR, Rastall RA (2005) Influence of disaccharide
structure on prebiotic selectivity in vitro. J Agric Food Chem
53:5192–5199
Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier L, Beaugerie
L, Cosnes J, Corthier G, Marteau P, Dore J (2009) Low counts of
Faecalibacterium prausnitzii in colitis microbiota. Inflamm
Bowel Dis 15:1183–1189
Stratton J, Chiruvolu V, Meagher M (1998) High cell-density
fermentation. In: Pichia protocols, 103rd edn. Humana Press,
Totowa, NJ, pp 107–120
Thomassen LV, Meyer AS (2010) Statistically designed optimisation
of enzyme catalysed starch removal from potato pulp. Enzyme
Microb Technol 46:297–303
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER,
Gordon JI (2006) An obesity-associated gut microbiome with
increased capacity for energy harvest. Nature 444:1027–
1031
Van den Broek LAM, denAantrekker ED, Voragen AGJ, Beldman G,
Vincken JP (1997) Pectin lyase is a key enzyme in the
maceration of potato tuber. J Sci Food Agric 75:167–172
Van Laere KMJ, Hartemink R, Bosveld M, Schols HA, Voragen AGJ
(2000) Fermentation of plant cell wall derived polysaccharides
and their corresponding oligosaccharides by intestinal bacteria. J
Agric Food Chem 48:1644–1652
Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM,
Munro K, Alatossava T (2000) Detection and identification of
gastrointestinal Lactobacillus species by using denaturing gradi-
ent gel electrophoresis and species-specific PCR primers. Appl
Environ Microbiol 66:297–303


















































Journal Identiﬁcation = PRBI Article Identiﬁcation = 9143 Date: March 22, 2011 Time: 7:15pm
Process Biochemistry 46 (2011) 1039–1049
Contents lists available at ScienceDirect
Process Biochemistry
journa l homepage: www.e lsev ier .com/ locate /procbio
Tailored enzymatic production of oligosaccharides from sugar beet pectin and
evidence of differential effects of a single DP chain length difference on human
faecal microbiota composition after in vitro fermentation
Jesper Holcka, Karin Hjernøb, Andrea Lorentzenb, Louise K. Vigsnæsc, Lene Hemmingsenc,
Tine R. Lichtc, Jørn D. Mikkelsena, Anne S. Meyera,∗
a Center for Bioprocess Engineering, Department of Chemical and Biochemical Engineering, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark
b Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense M, Denmark
c National Food Institute, Division of Microbiology and Risk Assessment, Technical University of Denmark, 2860 Søborg, Denmark
a r t i c l e i n f o
Article history:
Received 27 September 2010
Received in revised form 9 January 2011








a b s t r a c t
Sugar beet pectinwasdegradedenzymatically and separatedby ionexchange chromatography into series
of highly puriﬁed homogalacturonides and rhamnogalacturonides. MALDI-TOF/TOF mass-spectrometry
was used to determine sizes and structural features. The methodology was based on the sequential use
of monocomponent enzymes that were selected to target speciﬁc substructures in the sugar beet pectin.
Notably pectin lyase and rhamnogalacturonan I lyasewere used,which allowed detection of the resulting
cleavage products by UV spectroscopy. Seven different homogalacturonides (HG) with degrees of poly-
merization (DP) from 2 to 8 and six different rhamnogalacturonide (RGI) structures, ranging from DP4
to 6 with deﬁned galactose substitutions were puriﬁed. Total recoveries of 200mg homogalacturonides
and 67mg rhamnogalacturonides per gram sugar beet pectin were obtained. This integrated bioreﬁning
method provides an option for advanced upgrading of sugar beet pectin into HG and RGI oligosaccharides
of deﬁned size and structure. In vitro microbial fermentation by human faecal samples (n=9) showed a
different response to the DP4 and DP5 HG structures on the ratio between Bacteroidetes and Firmicutes.
This indicates that pectic oligosaccharideswith only slightly different structures have signiﬁcantly differ-
ent biological effects. This is the ﬁrst report of pectic oligosaccharide activity on gut bacterial populations
related to the metabolic syndrome associated with obesity.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Side-streams from agricultural industries are the subject of a
number of studies to generate added-value products. From the
sugar industry, sugar beet pulp comprises more than 4 million
tons/year in the European Community. Sugar beet pectin is a major
fraction of this renewable resource, but has so far only been uti-
lized commercially for a limited number of applications [1]. Pectin,
including sugar beet pectin, is one of the most structurally com-
plex types of polysaccharides in nature. Pectin is generally deﬁned
as a heteropolysaccharide predominantly containing galacturonic
acid (GalA) residues that are organized in a pattern of “smooth”
Abbreviations: HG, homogalacturonan; RGI, rhamnogalacturonan I; SB, sugar
beet.
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homogalacturonan (HG) regions and ramiﬁed “hairy” rhamno-
galacturonan I (RGI) regions in which neutral sugars are present as
side chains. HG consists of linear stretches of-1,4-linked galactur-
onic acid residues,which are partiallymethoxylated at the carboxyl
group and O-acetylated on O-2 and/or O-3. The length of HG in
sugar beet pectin is relatively shorter than the HG from citrus and
apple [1]. The acetylation in sugar beet pectin can be as high 50%
as reported by Levigne et al. [2]. The backbone of RGI is composed
of the repeating disaccharide [→2)--l-Rhap–(1→4)--d-GalpA-
(1→], and, depending on the source [3], 20–80% of the rhamnose
moieties may be substituted at the O-4 position with arabinan
(-1,5-linked arabinose with some -l-araf substitutions at C-2
or C-3), galactan (-1,4-linked galactose) and/or arabinogalactan
(Fig. 1A). RGI can also be O-acetylated at the O-3 position of galac-
turonic acid. The amount of RGI in sugar beet pectin is relatively
higher compared to apple and citrus pectin, comprisingup to 25%of
the dryweight [4]. Furthermore RGI side chains in sugar beet pectin
are particularly rich in arabinosemoieties [5]which are substituted
with ferulic acid (approximately 1% (w/w). Most of the ferulic acids
are bound as monomers, but some as various types of dimers [6].
1359-5113/$ – see front matter © 2011 Elsevier Ltd. All rights reserved.
doi:10.1016/j.procbio.2011.01.013
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Fig. 1. (A) Schematic illustrationof sugar beet pectin structural elements. (B) Schematic ﬂowsheet for bioreﬁning strategy indicating the enzymatic treatments andmembrane
separation steps.
Finally sugar beet pectin contains minor amounts of rhamnogalac-
turonan II (RGII), that has a backbone similar to HG substituted
with side chains of a complex structure and composition [7]. The
combination of shorter HG chain length, high degree of acetylation
and the large amount of side chains contributes to the poor gelling
properties of sugar beet pectin [1].
Several studieshave indicatedhealthpromotingeffectsofpectin
derived compounds. These effects include (i) prebiotic effects that
selectively increase growth and/or activity of bacteria considered
to be probiotic such as Biﬁdobacterium and Lactobacillus strains
[8–12], (ii) modiﬁcation of the ratio between subgroups of the
phyla Bacteroidetes and Firmicutes [13], and (iii) a decrease in the
growth of potentially pathogenic bacteria like clostridium [11]. It
has also been reported that certain pectin derived oligosaccharides
reduce the binding of E. coli Shiga-like toxin in human colonic
adenocarcinoma cell receptors [14], induce apoptosis in human
colonic adenocarcinoma cells [15] and prostate cancer cells [18],
inhibit proliferation of several types of cancer along with antioxi-
dant effects [16], and increaseurinaryexcretionof toxicmetals [17].
A common theme in numerous papers regarding health promoting
effects of pectin is the dependency of size of the applied poly- and
oligosaccharides [12,14,16]. Nevertheless, the studies assessing the
putative bioactivity of pectin have been performed using mixtures
of heterogeneous pectin derived fractions with a relatively broad
size distribution [9–11,18,19]. Several studies based on the pec-
tic oligosaccharides generated by Olano-Martin et al. [20] revealed
that a low methoxyl fraction with a binominal molecular weight
distribution of approximately 3.8 kDa and 0.97kDa (roughly cor-
responding to DP21–23 and DP5–6) showed better potential as a
health promoting candidate than a high methoxyl fraction with
a molecular weight of approximately 3.5 kDa (corresponding to
DP20–21). The work by Manderson et al. [8] and Mandalari et al.
[9] indicated that pectic oligosaccharides with DP <10 had opti-
mal biﬁdogenic effects. The same pectic oligosaccharide fraction
used by Manderson et al. [8], which contained methyl-esteriﬁed
HG and RGI oligosaccharides, also inhibited the adhesion of E. coli
to human colonic adenocarcinoma cells [21]. However, a pectic
oligosaccharide fraction enriched in RGI oligosaccharides inhibited
the invasion of Caco-2 cells by Campylobacter jejuni but did not
inﬂuence bacterial adhesion to these cells [22]. Subtle differences
in pectic oligosaccharide structure thus appear to signiﬁcantly alter
the health-promoting biological activity. The use of pectic oligosac-
charide mixtures can therefore obscure the results, and prevent a
detailed understanding of possible structure function relationships
of pectin derived oligosaccharides in relation to health promoting
effects.
Pectic oligogalacturonides have previously been successfully
prepared at the preparative scale by use of Aminopropyl-silica,
Q-sepharose, CarboPac PA1 or PA100 chromatography [23–26].
Notably, gramquantities of saturated andunsaturatedHGoligosac-
charides up to DP7 were prepared following polygalacturonase
and pectate lyase degradation of citrus polygalacturonic acid [23]
and milligram quantities of homogalacturonides up to DP20 from
autoclaved, hydrolyzed citrus polygalacturonic acid were also pre-
pared [25]. Similarly, apple pectin derived rhamnogalacturonides
have been isolated by a combination of preparative scale size-
exclusion and ion exchange chromatography with CarboPac PA1
or PA100 columns [26,27]. The homogalacturonide separation
method described by Hotchkiss et al. [23] was fast, had high
sample load capacity and a good isolation efﬁciency range of
10–136mg/peakh, whereas the work done by Mutter et al. and
Schols et al. [26,27] was mainly designed to examine speciﬁc enzy-
matic action and degradation of pectic hairy regions, with less
emphasis on achieving high recoveries and quantiﬁcation of the
oligomers.
This article introduces a method for integrated production
of homogalacturonan and rhamnogalacturonan oligosaccharides
with a deﬁned degree of polymerization. The method builds on
sequential dissection of sugar beet pectin using monocomponent
enzymes, membrane separations, and ion exchange chromatogra-
Journal Identiﬁcation = PRBI Article Identiﬁcation = 9143 Date: March 22, 2011 Time: 7:15pm
J. Holck et al. / Process Biochemistry 46 (2011) 1039–1049 1041
Table 1
List of enzymes.
Enzyme Source pH optimum Temperature
optimum
EC number Family Reference
Pectin lyase Aspergillus nidulans 7.0 n.a. 4.2.2.10 PL 1 [29]
-Galactosidase-1 Aspergillus niger 4.0–4.5 60 ◦C 3.2.1.23 GH 35 Megazyme
-Galactosidase-2 Kluyveromyces lactis n.a. n.a. 3.2.1.23 GH 2 n.a.
-Galactanase Aspergillus niger 4.0–4.5 50 ◦C 3.2.1.89 GH 53 Megazyme
-Arabinofuranosidase Aspergillus aculeatus 4.0–4.5 30 ◦C 3.2.1.55 – [50]
-Arabinanase Aspergillus aculeatus 5.5 30 ◦C 3.2.1.99 GH 43 [50]
RGI lyase Bacillus licheniformis 8.0–8.5 60–65 ◦C 4.2.2.– – Unpublished data
phy to obtain the structural elements and avoids the use of organic
solvents. To assess the possible effect of different chain length, the
study includes evaluation of the biological activity of homogalac-
turonan oligosaccharides DP4 and DP5 based on their capacity to
alter the ratio between Bacteroidetes and Firmicutes, which rep-
resent the dominant bacterial phyla in the human intestine. This
is assessed by in vitro bacterial fermentation using human faecal
samples.
2. Materials and methods
2.1. Substrate
Sugar beet pectin was obtained from Danisco A/S (Nakskov, Denmark). The
pectin had been prepared by sequential acid extraction with nitric acid from sugar
beet pulp, involving removal of insoluble cellulose, ultraﬁltration, and diaﬁltration
with a 50kDa cutoff essentially as described by Buchholt et al. [1], except that pre-
cipitation in isopropanol was replaced by spray drying. Degree of methoxylation
and acetylation were determined to be 59% and 20%, respectively.
2.2. Chemicals
Ammonium formate, Trizma-HCl, sodiumacetate, acetic acid, hepes,manganese
chloride, d-glucuronic acid, d-galactose, d-arabinose, d-fucose, l-rhamnose mono-
hydrate, d-galacturonic acid monohydrate, and -cyano-4-hydroxy-cinnamic acid
were purchased from Sigma–Aldrich (Steinheim, Germany) d-glucose and d-xylose
were purchased from Merck (Darmstadt, Germany). Triﬂuoroacetic acid was from
Riedel-deHaën (Seelze, Germany). High resolution Source 15Qanion exchange resin
and chromatography columns were obtained from GE Healthcare Biosciences (Upp-
sala, Sweden). All chemicals used were analytical grade.
2.3. Enzymes
Pectin lyase was produced by fermentation essentially as described by Strat-
ton et al. [28]. The Pichia pastoris clone transformed with the pectin lyase gene
AN2569.2 was obtained from the Fungal Genetic Stock Center as described by
Bauer et al. [29]. Rhamnogalacturonase I from Bacillus licheniformis was cloned and
expressed in P. pastoris (unpublished results). Galactanase and -galactosidase-1
were purchased from Megazyme (Bray, Co. Wicklow, Ireland), -galactosidase-2
was purchased from Sigma–Aldrich (Steinheim, Germany). 1 and 2 denotes the ori-
gin of gene, either Aspergillus niger (1) or Kluyveromyces lactis (2). Arabinanase and
-l-arabinofuranosidase were obtained from Novozymes (Bagsvaerd, Denmark)
(Table 1).
2.4. Bioreﬁning strategy
The sugar beet pectin was separated into homogalacturonan (HG) and rhamno-
galacturonan I (RGI) by sequentially applying monocomponent enzymes addressed
towards certain structures in the pectin molecule, followed by removal of the
released oligomers by membrane separation (Fig. 1B). Pectin lyase was employed
to catalyze the cleavage of methoxylated homogalacturonan by -elimination. This
gave rise to a double bond in between carbon 4 and 5 of galacturonic acid in the non-
reducing end of one of the cleavage products. In turn, this allowed the assessment of
the molar level of released products in the HG permeate by UV spectroscopy. Next,
enzymes active towards arabinan and galactan side chains of the RGI were added
to catalyze the release of arabinose and galactose oligomers and monomers. These
products were separated into the side chain (SC) permeate (Fig. 1). Finally RGI lyase
was added to the retentate to catalyze the cleavage of the remaining RGI backbone
by -elimination (Fig. 1) again introducing a detectable double bond. The released
RGI oligomerswere separated into the RGI permeate. Any unprocessedmaterialwas
found in the ﬁnal retentate.
2.5. Membrane reactions and separation
All reactions and separations were performed in a 200mL stirred membrane
reactor model 8200 (Millipore, Billerica, MA) equipped with a 3kDa regenerated
cellulose membrane (Millipore, Billerica, MA), connected to compressed nitrogen
for ﬂux regulation. The reactor contents were mixed by magnetic stirring using a
RCT basic magnetic stirrer (IKA, Germany). Temperature control was maintained
using a Julabo ED5 water bath (Julabo, Germany).
2.6. Pectin lyase treatment
A 3% (w/w) SB pectin solution in 50mM Tris buffer pH 8 was treated with 0.5%
E/S (enzyme/substrate) pectin lyase and incubated at 50 ◦C for 15h in a stirred and
thermostatically controlled reactor. The reaction mixture was transferred to the
membrane reactor and ﬁltration was performed at 50 ◦C and 2 bars. The retentate
was diaﬁltrated twice in 0.7 sample volumes of water. All permeate was pooled and
stored at 5 ◦C until further use.
2.7. Side chain degrading treatment
A 1.4% (w/w) RGI retentate solution in 50mM acetate buffer pH 5 was treated
with a mixture of 0.2% -galactosidase-1, 4.7% -galactosidase-2, 0.2% galactanase,
0.8% arabinofuranosidase, and 0.8% arabinanase (all percentages in % E/S) and incu-
bated in amembrane reactor at 45 ◦C for 16h. The enzymeswere dosed according to
a tentative estimateof the available concentrationof the speciﬁc structural substrate
element and the individual enzyme activity. Filtration was performed at 50 ◦C and 2
bars. The retentate was diaﬁltrated once in 1 sample volume of water. All permeate
was pooled and stored at 5 ◦C until further use.
2.8. RGI lyase treatment
Prior to the enzymatic treatment, RGI lyase was incubated in 100mM MnCl2
for 0.5h for activation [30]. A 0.75% (w/w) RGI backbone solution in 50mM Hepes
buffer pH 7.8 was treated with 0.5% E/S RGI lyase and incubated in a membrane
reactor at 60 ◦C for 2h. Filtration was performed at 60 ◦C and 2 bars. The retentate
was diaﬁltrated twice in 1 sample volume of water. All permeate was pooled and
stored at 5 ◦C until further use.
2.9. Alkaline deesteriﬁcation
Prior to ion exchange chromatography, methoxyl- and acetyl groups were
removed frompectic substancesusingcoldalkaline conditions. The lowtemperature
was used in order to prevent spontaneous -elimination [31]. Sample temperature
was lowered to approx. 5 ◦C and cold 2M NaOH was added under stirring until pH
13 and a ﬁnal concentration of 40mM NaOH was reached. Samples were incubated
for 24h. After incubation pH was adjusted using 1M acetate buffer pH 6.5 and 2M
HCl. Samples were diluted to conductivity under or equal to the conductivity of the
ion exchange buffer.
2.10. Ion exchange chromatography
Anion separation was performed at room temperature with an ÄKTA puriﬁer
100 work station equipped with a P-900 pump, UV-900 monitor, pH/C monitor,
and Frac-950 fraction collector, all controlled by UNICORN software. A HR16/10
column with a 23mL packed bed of high resolution Source 15Q was used for sep-
aration. The elution of the unsaturated oligosaccharides was monitored by the UV
absorption at 235nm and subsequently quantiﬁed by use of the molar extinction
coefﬁcient 4600M−1 cm−1 [32]. Baseline correction was made with a blank run. Elu-
tion was performed at a ﬂow rate of 10mL/min with water and ammonium formate
as eluents.
Before injection the column was equilibrated with 20mM ammonium formate
for two column volumes (CV). After injection the column was washed with 20mM
ammonium formate for three CV, followed by elution with a gradient speciﬁed
below. After elution the column was regenerated with 1000mM ammonium for-
mate for two CV and with water for three CV. To obtain the oligomers in the HG
permeate, a sample was injected on the column and eluted using a linear gradient
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Table 2
16S rRNA primers for real time PCR.





Firmicutes phylum gga gya tgt ggt tta att cga agc a agc tga cga caa cca tgc ac 126 0.999 101 [51]
Bacteroidetes phylum gga rca tgt ggt tta att cga tga t agc tga cga caa cca tgc ag 126 0.999 99 [51]
Total bacteriaa cgg caa cga gcg caa ccc cca ttg tag cac gtg tgt agc c 130 0.999 99 [52]
a PCR for the total bacteria primer set was run in parallel for each set of primers for all samples.
from 80 to 550mM ammonium formate for 20.25 CV. Collection of peaks of interest
was performed using a level fractionation parameter. To obtain the oligomers in the
RGI permeate, a sample was injected on the column and eluted using a linear gradi-
ent from 20 to 400mM ammonium formate for 30 CV. Fractionation was performed
using an elution volume as the fractionation parameter. The collected fractions for
both types of oligomers were lyophilized to remove water and ammonium formate
[33,34] and analyzed by MALDI-MS and MS/MS.
2.11. MALDI-MS
All mass-spectrometric analysis of the oligosaccharides was performed on a
4800 Plus MALDI TOF/TOFTM (AB SCIEX) mass spectrometer. 0.5l of the sam-
ple was applied to a stainless steel MALDI target and mixed with 0.5l of the
matrix,-cyano-4-hydroxy-cinnamic acid dissolved at a concentration of 10mg/mL
in 70%ACN/0.1% TFA/water. The instrument was operated in negative ion reﬂector
mode and the m/z range from 100 to 3500 was monitored. A total of around 1000
laser shots were applied to each sample in MS mode. In MS/MS mode around 2000
shots were obtained. The laser intensity was manually varied in order to obtain the
best possible spectra (MS: from 4500 to 4800. MS/MS: from 4800 to 5100). MALDI-
TOF-MS andMS/MSdatawere exported as text ﬁles usingDataExplorer (version 4.0)
and each spectrumwere smoothed, labeled and analyzedmanually inm/z (Genomic
Solutions®). For annotation of MS/MS spectra, the nomenclature suggested in [35]
was applied.
2.12. Combined acid and enzymatic hydrolysis
The monosaccharide composition of all fractions were determined by a com-
bined acid and enzymatic hydrolysis modiﬁed from Garna et al. [36]. Each substrate
was treated in 4mL ﬁnal volume of 0.2M triﬂuoroacetic acid having a substrate
concentration of 2.5 g/L for 72h at 80 ◦C. After acid hydrolysis, pH was adjusted to 5
using 500mM acetate buffer pH 5, followed by 5M NaOH. The acid hydrolysate was
treated with Viscozyme (Novozymes A/S, Bagsvaerd, Denmark) for 24h at 50 ◦C as
described in [36]. Samples were ﬁltered through a 0.2m ﬁlter prior to HPAEC-PAD
analysis. The recovery of monosaccharides was determined by performing the same
hydrolysis on d-fucose, l-rhamnose, d-arabinose, d-galactose, d-glucose, d-xylose,
d-galacturonic acid and d-glucuronic acid. The recovery factors were used to quan-
tify the monosaccharides. Relative standard deviation values were determined for
at least 3 measurements and ranged from 2 to 14%. The amount of fucose was below
the quantiﬁcation limit in all fractions.
2.13. HPAEC analysis
Quantiﬁcation of the monosaccharides was performed by HPAEC-PAD using
an ICS-3000 system consisting of a gradient pump (model DP-1), an electrochem-
ical detector/chromatography module (model DC-1) coupled to an autosampler
(Dionex Corp., Sunnyvale, CA). The separation was made using a CarboPacTM PA20
(3mm×150mm) analytical column based on a method of [37] with the following
modiﬁcations: a two-eluent system comprising deionized water and a 0.5M NaOH
aqueous solution was used. Before injection of each sample (10l) the column was
reequilibrated with 15mM NaOH for 10min. After injection of the sample a linear
gradient from 15mM NaOH to 5mM NaOH from 0 to 1.5min was applied, followed
by isocratic elutionwith 5mMNaOH from1.5 to 3min, another linear gradient from
5mM NaOH to 2.5mM NaOH from 3 to 7min, another isocratic elution with 2.5mM
NaOH from 7 to 12min, and a ﬁnal isocratic elution with 500mM NaOH from 12 to
25min. The eluent ﬂow rate was always kept at 0.5mL/min. The quantiﬁcation was
carried out using the external monosaccharide standards: d-fucose, l-rhamnose,
d-arabinose, d-galactose, d-glucose, d-xylose and d-galacturonic acid. The follow-
ing pulse potentials and durations were used for detection: E1=0.1V, t1=400ms;
E2=−2V, t2=20ms; E3=0.6V, m3=10ms; E4=−0.1V, t4=70ms. Data were col-
lected and analyzed with the program Chromeleon 6.80 SP4 Build 2361 software
(Dionex Corp., Sunnyvale, CA).
2.14. Subjects and faecal samples
Faecal samples were obtained from 6 patients with ulcerative colitis (UC) and 3
healthy volunteers.Within theUCgroup, 3 patientswere in remission and3patients
were in relapse at the time of sampling. None of the participants had been treated
with antibiotics for at least 2months before enrolment, and the 3 healthy volunteers
had no history of gastrointestinal disorder. Therewas no signiﬁcant difference in the
mean age of the participants comparing the 3 groups (healthy control: 42.7±10.0
years,UCpatients in remission:36.0±5.0yearsandUCpatients in relapse:44.3±5.5
years). Whole stools were collected in airtight containers, immediately stored at
4 ◦C and processed within 12h. 200mg wet weight faeces were collected for DNA
extraction, and at the same time, faeces were prepared for in vitro fermentation.
The faecal samples for in vitro fermentation were homogenised in 50% glycerol (1:1
dilution) in an anaerobic cabinet (containing 10% H2, 10% CO2, and 80% N2) and
stored at −80 ◦C until further analysis.
2.15. In vitro fermentation
A small scale in vitro fermentation method was developed to assess the fer-
mentability of selected oligosaccharides on human faecal samples. Sterile ﬁltered
homogalacturonan oligosaccharides DP4 and DP5 were added to autoclaved mini-
mal basal medium to give a ﬁnal concentration of 5 g/L in a total reaction volume of
2mL. The solutions were reduced in an anaerobic cabinet over night. The minimal
basal medium contained, per liter, 2 g of peptone water, 1 g of yeast extract, 0.1 g of
NaCl, 0.04 gofK2HPO4, 0.04 gofKH2PO4, 0.01 gofMgSO4·7H2O,0.01 gofCaCl2·2H2O,
2 g of NaHCO3, 0.5 g of bile salts, 0.5 g of l-cysteine hydrochloride, 0.005g of hemin,
10l of vitamin K1(0.02mM), 2ml of Tween 80, and 1mL of 0.05% (w/v) resazurin
solution. A 10% (w/v) faecal slurry was prepared by mixing the faeces diluted in 50%
glycerol with anoxic PBS (Oxoid, Greve, Denmark). The reduced minimal medium
with added oligosaccharide was inoculated with the faecal slurry to a ﬁnal concen-
tration of 1% (w/v) faeces. The fermentations were performed at 37 ◦C for 24h in an
anaerobic cabinet.
2.16. Extraction of bacterial DNA
DNA was extracted from faecal and fermentation samples using the QIAamp
DNA Stool Mini Kit (Qiagen, Hilden, Germany) with a bead-beater step in advance,
as described by Leser et al. [38]. The puriﬁed DNA was stored at −20 ◦C until use.
2.17. Real-time PCR assay conditions
AmpliﬁcationanddetectionofpuriﬁedbacterialDNAby real-timePCRwereper-
formed with the ABI-Prism 7900 HT from Applied Biosystems using optical grade
384-well plates. Primers speciﬁcally targeting 16S rRNA gene sequences of the Bac-
teroidetes and Firmicutes phyla, respectively, were included in the qPCR analysis
(Table 2). The ampliﬁcation reactions were carried out in a total volume of 10l
containing; 5l EXPRESS SYBR® GreenERTM qPCR SuperMix (Invitrogen A/S, Taas-
trup, Denmark), 10 pmol of each of the primers (Euroﬁns MWG Synthesis GmbH,
Ebersberg, Germany), 2l template DNA, and Nuclease-free water (Qiagen) puri-
ﬁed for PCR. The ampliﬁcation program consisted of one cycle at 50 ◦C for 2min;
one cycle at 95 ◦C for 10min; 40 cycles at 95 ◦C for 15 sec and 60 ◦C for 1min; and
ﬁnally one cycle of melting curve analysis for amplicon speciﬁcity at 95 ◦C for 15 s,
60 ◦C for 20 s and increasing ramp rate by 2% until 95◦ for 15 s.
2.18. Realtime PCR data handling
The threshold cycle (Ct) values and baseline settings were determined by
automatic analysis settings set by the ABI software. The relative changes in the
abundancy of gene targets encoding 16S rRNA of Bacteroidetes and Firmicutes were
calculated using the approximation 2−Ct. Ct is the threshold cycle calculated by the
ABI software as the PCR cycle, where ampliﬁcations signal exceeds the selected
threshold value, also set by the software. The amounts of phylum speciﬁc DNA tar-
getswere normalized to total bacteria DNA targets in order to correct for differences
in total DNA concentration between individual samples [39]. Standard curves were
created using serial 10-fold dilutions of bacterial DNA extracted from one of the
fermentation samples for all primer sets. Analysis of the standard curves allowed
veriﬁcation of PCR efﬁciency for the chosen PCR conditions (Table 2). All resultswere
calculated as means of duplicate determinations.
2.19. Statistical analysis
Statistical analysis of quantitative PCR data was done using the GraphPad Prism
(version5.03). Datawas analyzedbyone-wayANOVA followedby apair-wisemulti-
ple comparison ofmeans (Student’s t). Testswere considered statistically signiﬁcant
if P values <0.05 were obtained.
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Table 3
Mass balance in percentage based on dry matter content vs. theoretical mass. The molar distribution of monosaccharides is based on the quantiﬁcation of each main
monosaccharide (without considering methylation and acetylation) in each fraction compared to the total amount in 1g of the starting material. Data for glucose and
glucuronic acid is not shown.
Observed mass Theoretical mass Rhamnose Arabinose Galactose Galacturonic acid
mmol % mmol % mmol % mmol %
SB pectin 100 100 0.35 100 0.91 100 0.68 100 3.53 100
HG permeate 63 56 0.00 0 0.44 49 0.14 21 2.74 78
SC permeate 19 23 0.10 29 0.35 38 0.29 44 0.35 10
RGI permeate 11 11 0.12 34 0.00 0 0.13 19 0.15 4
Final retentate 2 0 0.01 1 0.00 0 0.01 2 0.02 1
Other 5 4 0.13 35 0.12 13 0.11 15 0.30 8
3. Results and discussion
3.1. Mass distribution
Based on the monosaccharide composition of each fraction
(without considering the degrees of methyl and acetyl esteriﬁca-
tion) an overall mass balance and the molar distribution of each
of the major monosaccharides were calculated. Assuming an ideal
distribution of the enzymatically cleaved pectin products, the theo-
retical masses of each fraction was calculated and compared to the
observed masses for the dry matter mass distribution (Table 3). As
expected from the general pectin structure, the highest mass (63%)
was found in the HG permeate (Table 3). The experimental mass of
the HG permeate was slightly higher than the expected theoreti-
cal mass, whereas the experimental SC permeate mass (19%) was
correspondingly smaller than the expected theoretical mass. This
slight discrepancy was presumably due to the recovery of some
arabinose and galactose in the HG permeate (Table 3) (discussed
further below).
3.2. Molar distribution
On a molar basis, the HG permeate following the pectin lyase
treatment contained 78% of the total galacturonic acid from SB
pectin and the composition of HG permeate was dominated by
galacturonic acid (Table 3), suggesting that the HG permeate, as
expected, was mainly made up of galacturonides. Relatively high
levels of arabinose and some galactose were found in the HG
permeate (Table 3), but since no rhamnose was found in this frac-
tion, presumably the arabinose and galactose must have existed
as monomers or oligosaccharides in the SB pectin prior to the ﬁrst
enzymatic treatment. The pectin in native sugar beet pulp is rich
in arabinan present as side chains on the RGI [5]. Since these arabi-
nan side chains are particularly acid labile [1], the amounts (molar
levels) of free arabino-oligomers and even arabinose monomers
were higher than the levels of galacto-oligomers and galactose in
the pectin (Table 3). During the industrial preparation, the pectin
had been puriﬁed via combined diaﬁltration and concentration via
ultraﬁltration, but the arabino-oligomers and any monomeric ara-
binose were apparently not liberated from the pectin during this
procedure, presumably because of the high viscosity. Hence, when
the pectin backbone was degraded the arabinose and arabino-
oligomers were apparently liberated. Regardless, the presences of
arabino-oligomers and/or arabinose in the HG permeate did not
affect thepurityof theﬁnalHGoligomersobtainedby ion-exchange
chromatography (see below). Similarly some glucose was found
mainly in the HG permeate (data not shown), indicating that also
glucose was present at mono- or oligomers prior to enzymatic
treatment. As for arabinose and galactose, some glucose might be
present in the pectin since the diaﬁltration step in the industrial
pectin isolation process cannot completely remove all monomers
and very low DP oligosaccharides. The SC permeate contained 10%
of total galacturonic acid, and 38% and 44% of the total molar level
of arabinose and galactose respectively. The SC permeate also con-
tained 29% of total rhamnose. The occurrence of galacturonic acid
and rhamnose in the SC permeate might be due to liberation of
smaller RGI molecules during the pectin lyase treatment. These
molecules were not small enough to pass through the 3K MWCO
membrane along with the HG permeate, but after applying the side
chain degrading enzymes, the naked RGI backbones were small
enough to pass through the membrane. A molecule consisting of
alternating galacturonic acid and rhamnose with a DP of 10 will be
small enough to pass through this membrane. The employment of
a membrane with a lower cut-off would have increased the reten-
tion of RGI-like molecules, but would concurrently have decreased
the ﬂux signiﬁcantly. The presence of non-equimolar amounts of
rhamnose and galacturonic acid was presumably due to insufﬁ-
cient washing of the RGI retentate during the removal of the HG
permeate. In theRGI permeate, theﬁnding of equimolar amounts of
galacturonic acid (0.15mmol) and rhamnose (0.12mmol) indicated
a RGI backbone structure of alternating rhamnose and galacturonic
acid residues. Relatively high levels of galactose, almost equimo-
lar to the levels of rhamnose and galacturonic acid, were also
found in the RGI permeate. Despite the use of high doses of two
different -galactosidases, the obtained data indicated an insufﬁ-
cient enzymatic treatment with -galactosidase – the galactanase
alone is unable to catalyze the removal of all galactose from the
RGI backbone [40]. The incomplete removal of galactose from the
RGI backbone was reported previously [41] where smaller RGI
backbone oligomers apparently were a more suitable substrate
for -galactosidase than the longer RGI polymers. In contrast, no
detectable amounts of arabinose were found in the RGI permeate,
which indicated an efﬁcient arabinose removal in the side chain
degrading step.
3.3. Puriﬁcation of homogalacturonan oligosaccharides
After alkaline deesterﬁcation, the HG permeate was puriﬁed
by anion exchange chromatography and the peaks were detected
by UV monitoring at 235nm (Fig. 2). Fractions were collected,
lyophilized and analyzed by MALDI-TOF MS for structural veriﬁ-
cation. Each fraction resulted in a mass spectrum containing one
or two major components together with minor impurities (pri-
marily matrix peaks). The MS spectra clearly showed that the
procedure for deesteriﬁcation was successful. The structure of the
oligogalacturonides was determined by MS/MS analysis. As exem-
pliﬁed in Fig. 3, the MS/MS spectra of the component in fraction
H7 revealed several C type fragments resulting from sequential
losses of 176. For the pure oligogalacturonides these were found
to be equivalent in mass to the Z type fragments, in accordance
with the fragmentation nomenclature suggested by Domon and
Costello [35]. The m/z value of the C1-ion is only 175 instead
of 193 due to the -elimination action of pectin lyase. The frac-
tionation pattern with C and Z type ions in abundance and the
presence of a -60 Da ion is in complete accordance with the results
obtained for unsaturated unmethylated oligogalacturonides previ-
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Fig. 2. Elution proﬁle of deesteriﬁed HG permeate during ionic exchange chromatography on a Source 15Q packed HR16/10 column using a linear gradient of ammonium
formate and UV detection at 235nm. For peak codes, refer to Table 4.
ouslydescribedbyKorneret al. [42].Hence fractionsH2,H5,H7, and
H9-12 (Fig. 2) were conﬁrmed to contain unsaturated oligogalac-
turonides with a degree of polymerization (DP) of 2–8 respectively
(Table 4).
FractionH1 containedDP2with some impurities. The faster elu-
tion of the DP2 molecules in H1 compared to H2 (Fig. 2) might be
due to interference of the binding to the quaternary ammonium ion
in the SourceQmatrix by the impurities. FractionH3,H4,H6, andH8
all contained compoundswithmasses corresponding to theweight
of unsaturatedoligogalacturonides+103.MS/MSdataon these frac-
tions also revealed several fragments with sequential losses of 176,
i.e. consistent with oligogalacturonide fragments. MS/MS analysis
revealedbothCandZ typeof ions (Fig. 4), but thedeﬁnite structures
were not obtainable. These types of compounds were also found in
fraction H9-H11, but only in minor amounts. Further studies are
needed to determine the exact structure of these sugars, but the
spectrum clearly reveals the existence of a homogalacturonan as
the backbone of the structure.
The yields of each type of homogalacturonide ranged from
approximately 6 to 46mg for each g of initial SB pectin, with a
total recovery of approximately 200mg HG oligomers/g SB pectin
(Table 4). The yield of each type of compound per run ranged
from 9 to 73mg/g sample load. With the column capacity and
ﬂow rate employed this was equivalent to an isolation efﬁciency
of 0.6–4.2mg/peakh. This recovery range was not as high as that
reported by Hotchkiss et al. [23], but somewhat better than that
reported by Hotchkiss et al. [25], albeit they isolated longer oli-
gogalacturonides (DP8–20). Since the HG permeate accounted for
0.6 g of 1 g initial pectin, as indicated in the mass balance (Table 3),
one third of this mass was thus recovered as pure and deﬁned
homogalacturonides and is equivalent to a recovery of 20% from
initial sugar beet pectin. It can be assumed that peaks eluted later
Fig. 3. MS/MS high energy CID spectrum of galA4 (H7, Fig. 2) illustrating the fragmentation pattern and nomenclature, and the proposed structure for the unsaturated galA4.
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Fig. 4. MS/MS high energy CID spectrum of the MS peak at 1157.9, H8 (Fig. 2). The mass is found to be 103 higher than DP6 (or 73 less than DP7). The spectrum is annotated
assuming that the extra 103Da is located in the reducing end. In case it is located in the non-reduced end, the C and Z ions should be reversed.
Table 4
Identiﬁed compounds, peak identity and yields from HG permeate. Yield in mg/g
initial pectin. For peak identities, refer to (Fig. 2). Yields are given as means and
coefﬁcient of variance were in the range of 1.3–3.1%.










than H12 will contain homogalacturonides with a DP above 8, and
thereby could add approximately 50mg/g pectin. However, since
no veriﬁcation by MS/MS was performed, these putative homo-
galacturonides couldnotbe taken into account in the total recovery.
Likewise it can be assumed, based on MS/MS data, that H3-4, 6, 8
(Fig. 2) roughly could add additional 50mg/g pectin to the overall
yield, since these peaks also contained some galacturonic acid.
3.4. Puriﬁcation of rhamnogalacturonan I oligosaccharides
Analogously to the procedure used for the HG permeate, the
RGI permeate was de-esteriﬁed by alkaline treatment and puri-
ﬁed by anion exchange chromatography (Fig. 5). Fractions were
collected, lyophilized and analyzed by MALDI-TOF MS and MS/MS
for structural determination. The major compound of peak R1 was
found to be galA2rha2gal2 and the MS/MS data proved that the two
galactose molecules were evenly distributed, one on each rham-
nose (Fig. 6). The MS/MS spectrum illustrated a characteristic loss
involving an A type cross-ring cleavage of the rhamnose as dis-
cussed in [43] (Fig. 7). No further studies were done to determine
which of the bonds were cleaved as this was not relevant for the
study. The residual ion, a cross ring fragment, is denoted CRFx, x
denoting the number of the cleaved monomer. These characteris-
tic CRF ions were seen in all the examined MS/MS spectra of the
RGI like compounds. Fraction R1 also contained trace amounts of
galA2rha2gal3. Contrary to the major compound, which was found




















Fig. 5. Elution proﬁle of deesteriﬁed RGI permeate during ionic exchange chro-
matography on a Source 15Q packed HR16/10 column using a linear gradient of
ammonium formate and UV detection at 235nm. For peak codes, refer to Table 5.
to have one galactose on each rhamnose, the MS/MS spectrum
showed all 3 galactose units to be localized on a single rham-
nose, either the one located in the reducing end or the one next
to the non-reduced unsaturated galacturonic acid (the spectrum
revealed a mixture of both) (data not shown). R2 contained a
galA2rha2gal molecule. MS/MS data showed that this peak com-
prised of a mixture of two kinds of structures with the galactose
on either the reducing-end rhamnose or on the internal rhamnose.
R3 was pure galA2rha2 with no traces of other compounds. R4 con-
tained mainly galA3rha3gal3 with one galactose on each rhamnose.
Also trace amounts of putative galA2rha2gal2 were observed, but
this structure was not conﬁrmed by MS/MS analysis. R5 contained
galA3rha3gal2 in a mixture of compounds with the unsubstituted
rhamnose in either the reducing end, the middle position, or next
to the non-reducing unsaturated galacturonic acid. The MS spec-
trum of peak R6 revealed two different components. One of them
being galA3rha3, the other one being galA3rha2gal2. MS/MS anal-
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Fig. 6. MS/MS high energy CID spectrum of galA2rha2gal2 (R1, Fig. 5) illustrating the fragmentation pattern and nomenclature, and the proposed structure.
ysis of galA3rha2gal2 revealed the co-existence of two different
structures (Fig. 8A and B). One of the structures consisted of two
galacturonic acids, the non-reducing being unsaturated, followed
by a rha-galA-rha segment with both rhamnoses substituted with
a single galactose (Fig. 8A). This molecule corresponded well with
thepreviousﬁndings of the connecting linkage betweenhomo- and
rhamnogalacturonan I in apple pectin [44] but this is the ﬁrst report
of this connecting linkage in sugar beet pectin. The second struc-
ture showed an alternating galacturonic acid-rhamnose backbone
structure, but with a galacturonic acid in both the reducing and
the non-reducing end, the latter being unsaturated. Galactose was
distributed evenly (Fig. 8B). These two structures indicated that
rhamnogalacturonan I is covalently linked to homogalacturonan in
both the reducing and the non-reducing end in sugar beet pectin.
Particularly the ﬁnding of the two consecutive galacturonic acid
moieties in R6 supports the comprehension of pectin being built of
consecutive homogalacturonan and rhamnogalacturonan I struc-
tural elements. In turn, this ﬁnding rejects the alternative model
structure proposed by Vincken [45] with homogalacturonan being
a side chain of the rhamnogalacturonan I backbone.While the ﬁnd-
ing of the molecule with a galacturonic acid in both the reducing
andnon-reducing endalso supports the classic pectinmodel (Fig. 1)













Fig. 7. Type A cross-ring cleavage of rhamnose in a RGI subfragment (CRFx). As an
example of a potential cleavage pattern an A1,3 cleavage is indicated by a dotted line.
Principle adapted from [43].
Table 5
Identiﬁed compounds, peak identity and yields from RGI permeate. Yield in mg/g
initial pectin. For peak identities, refer to (Fig. 5).









The yield for each RGI like oligosaccharide ranged from 5 to
20mg/gpectinwitha total of 67.6mg/gpectin (Table5). Theyieldof
each type of compound per run ranged from47 to 184mg/g sample
load. This yield per sample load is larger than reported for homo-
galacturonides due to a smaller population of different molecules
in the sample.With the employed chromatography conditions, this
yieldwas equivalent to an isolation efﬁciency of 0.1–0.4mg/peakh,
which was much lower than for the homogalacturonides, but the
sample loadwas never increased in order to increase the efﬁciency.
The yield of R6 was based on an average molecular weight of the
two compounds described, since no quantiﬁcation was possible.
According to the mass balance, the RGI permeate accounted for
110mg/gpectin. Out of this, approximately 60%was thus recovered
as deﬁned RGI like molecules. As seen for the homogalacturonides,
the chromatographic elution proﬁle of RGI permeate (Fig. 5) indi-
cated the presence of small amounts of RGI like molecules with
higher DP than the one observed in R6, but the lack of MS/MS veri-
ﬁcation prevented these peaks from further investigation and yield
calculations.
3.5. In vitro fermentation
Quantitative RealTime PCR from in vitro fermentations showed
differences in the relative ratio of Bacteroidetes and Firmicutes
dependent on the type of substrate. The density of Bacteroidetes
was signiﬁcantly lower in both fermentations compared to the
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Fig. 8. MS/MSHigh energy CID spectrum of the two identiﬁed galA3rha2gal2 structures illustrating the fragmentation pattern and nomenclature, and the proposed structures
of the compound with two galacturonic acids in the non-reducing end (A) and the molecule with galacturonic acid on both reducing and non-reducing end (B). The fragments
interpreted as resulting from CID of component B is marked with an asterisk.
inocula (DP4 and DP5 compared to inocula; P<0.001 and P<0.01,
respectively). The density of Firmicutes was signiﬁcantly higher
in the faecal samples fermented on DP4 compared to the inocu-
lum (P<0.001). Surprisingly, fermentation of homogalacturonan
oligosaccharides with DP5 yielded a density of Bacteroidetes which
was signiﬁcantly higher than obtained by fermentation of DP4
(P<0.05), while conversely, fermentation of the DP4 substrate
resulted indensities of Firmicutes signiﬁcantlyhigher thanobtained
after fermentation of DP5 (P<0.01) (Fig. 9). No differences between
the effects on microbial communities obtained from healthy sub-
jects, UC patients in remission, and UC patients in relapse were
detectable.
The two bacterial phyla Firmicutes and Bacteroidetes together
constitute the major part of the intestinal microbiota. The relative
increase in one of these phyla may therefore be accompanied by a
relative decrease in the other one. It is nevertheless still the balance
between the Bacteroidetes and Firmicutes phyla that is believed to
play a role in risk of obesity development [46]. Hence, the potential
biological effect of a modiﬁed ratio of Bacteroidetes and Firmicutes
might be beneﬁcial with respect to treatment of intestinal inﬂam-
mation, but needs further investigation.
3.6. Biological evaluation of homogalacturonan oligosaccharides
The literature about prebiotic activities of pectic oligosaccha-
rides is mainly focused on hydrolase-produced oligosaccharides.
In this study oligosaccharides with unsaturated non-reducing































































































Fig. 9. Relative amounts of target genes in samples from original bacterial communities, and after fermentation of DP4 and DP5 by these microbial communities. Target
genes encoded 16S rRNA from Bacteroidetes (A) and Firmicutes (B). Faecal samples were obtained from three healthy subjects (), three ulcerative colitis patients in remission
() and three ulcerative colitis patients in relapse (). The horizontal lines show the mean of the nine observations. Asterisks indicate a signiﬁcant difference among groups
P<0.05 (*); P<0.01 (**); P<0.001 (***).
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requires a different pathway than metabolism of saturated galac-
turonic acid, as described for Erwinia and Pseudonomas species
[47,48], but previous studies by Dongowski and Anger [49] showed
that unsaturated pectic oligosaccharides were formed as inter-
mediate metabolites in in vitro fermentation of pectin by human
faecal microbiota. This indicates that the human gut microbiota
is able to metabolize unsaturated galacturonic acid residuesas the
data obtained in the present study also suggests. The homogalac-
turonan oligosaccharides described in this paper (DP2–8, without
methyl esteriﬁcation) are candidates for in vitro prebiotic activ-
ity based on the literature and will be the subject of our future
investigation.
4. Conclusions
The present work provided a new lean method for bioreﬁn-
ing of pectin involving the sequential targeted enzyme catalyzed
dissection to produce homogalacturonides and rhamnogalactur-
onides of deﬁned molecular size. The results showed that it was
possible to separate individual HG oligomers with DP from 2 to
8, as well as short RGI oligomers by one integrated procedure.
The RGI oligomers were separated with respect to the number
of repeating backbone units, and also with respect to galactose
substitutions. The detailed MS/MS analysis revealed the presence
of RGI molecules containing either two consecutive galacturonic
acid moieties in the non-reducing end or a galacturonic acid in
both reducing and non-reducing end, indicating the covalent link
between homogalacturonan and rhamnogalacturonan I in sugar
beet pectin. An interesting spin-off result was the ﬁnding of the
molecular structure containing two consecutive galacturonic acid
attached to a rhamnose, which rejects the alternative pectin struc-
ture proposed by Vincken et al. [45]. This integrated method
provides an option for production of at least milligram quanti-
ties of high purity HG and RGI oligosaccharides of deﬁned size and
structure. The production of larger amounts and/or industrial scale
production by use of this methodological strategy may require fur-
ther optimization with respect to the cost of the chromatographic
downstream processing. The availability of well deﬁned structures
makes it possible to examineanddevelopan improvedunderstand-
ing of the functionality and possible bioactivity of pectin derived
structural elements. An important further directionmay also be the
comparison of the putative prebiotic activity of unsaturated vs. sat-
urated pectic oligosaccharides. In vitro assessment of the inﬂuence
of DP4 and DP5 homogalacturonides on the relative abundance
of two different bacterial phyla in faecal microbial communities
revealed a signiﬁcantly different effect of the two slightly different
structures, which opens a range of possibilities for further research
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7.1. Compositional changes of the fecal microbiota and their capacity to 
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